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Chronic pain affects approximately 100 million Americans annually. Heart rate 
variability and skin conductance have been used separately as measures of pain 
intensity. Current methods of assessing pain intensity have some limitations as they 
completely rely on subjective pain scales, require the patient’s cooperation, and 
completely fail in unconscious patients. Therefore, there is a need for an objective 
method of measuring pain to improve the quality of pain management. Understanding 
the relationship between heart rate variability and skin conductance can be beneficial 
for non-pharmacological treatments of pain such as biofeedback training, as combining 
both signals can be used to create a more powerful tool to measure pain. To identify a 
relationship between skin conductance and heart rate variability, we propose a cross-
correlation analysis. Such approach necessitates collection of baseline data on healthy 
college students, administration of a thermal stimuli, and collection of data during and 
after the stimuli.  
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Chapter 1: Introduction  
1.1 Overview 
The most important factors in successful pain management are accurately 
measuring and reporting pain levels. Many health care professionals rely on subjective 
measures of pain. Generally, pain is self-reported through a pain scale – ranking pain 
on a scale from 1 to 10 – as well as observing physical and behavioral cues. However, 
pain scales rely completely on the subject’s cooperation and their own understanding of 
pain which can lead to either understating or overstating pain levels.1 Furthermore, pain 
scales completely fail in unconscious, uncooperative, or other incapacitated subjects.2  
 It has been established that pain increases sympathetic tone, leading to a higher 
firing rate in sympathetic post-ganglionic cholinergic neurons.2–4 Such increase in 
activity of the sympathetic nervous system includes the activation of palmar sweat 
glands. Recent studies have linked skin conductance variability – numbers of skin 
conductance fluctuations – to pain levels.1, 2 Other studies have utilized heart rate 
variability coherent biofeedback (HRVB) – a tool to determine pain and stress 
management.5–7  
1.2 Aim 
Several studies have challenged the accuracy of popular pain scales such as the 
Behavioral Pain Scale (BPS) and the Critical-Care Pain Observation Tool which 
resulted in 72.04% and 70.8% accuracies, respectively.8 As a result, there is a need for 
an objective, quantifiable, subject-independent assessment of pain.2,9 Therefore, this 
study aims to combine two different measurements that have been used to assess pain 
levels: skin conductance (SC) 2,3,9–12 and heart rate variability (HRV) 6,10,11,13 via a cross-
correlation analysis. Specifically, the cross-correlation analysis will be performed on the 
two portions of the signals that are believed to be more closely correlated: the low 
frequency and high frequency components of HRV in the frequency domain and the 
phasic and tonic components of skin conductance found via non-negative 
deconvolution. 




It is believed that the high frequency components of HRV will be more closely 
correlated to the phasic components of skin conductance since this is where stimuli are 
more likely to be expressed, given that high frequency components are related to 
parasympathetic activity and tonic components are related to stimuli responses. 
Therefore, it is hypothesized that the cross-correlation between heart rate variability and 
skin conductance increases as pain level increases. The purpose of the proposed study 
is to combine HRV and skin conductance measurements to: (i) identify changes in HRV 
and skin conductance between baseline measurements and painful stimuli 
measurements, and (ii) identify a relationship between heart rate variability and skin 
conductance, using a cross-correlation analysis. It is expected that high frequency HRV 
cross-correlated with Phasic SC components will have a large correlation coefficient, 
while low frequency HRV cross-correlated with Tonic SC components will have a small 





Chapter 2: Background 
2.1 Autonomic Nervous System  
It is widely accepted that autonomic imbalance physiologically characterizes 
multiple medical and psychiatric disorders 15. The autonomic nervous system is divided 
into two main categories: the parasympathetic and the sympathetic nervous system. 
The parasympathetic nervous system is known as the “rest and digest” division that 
innervates many visceral organs as well as involuntary responses. The sympathetic 
nervous system is recognized as the “fight or flight” division that controls voluntary 
movement, including mass activation. Typically, introducing a stressor will increase the 
sympathetic response, while inducing relaxation will increase parasympathetic 
activity.7,14  
One measure of the autonomic nervous system is heart rate variability (HRV). 
Via spectral analysis, heart rate variability provides an index of sympathetic and 
parasympathetic activity15. Sweating is another measure of the peripheral autonomic 
nervous system. Normal sweat gland function requires sympathetic and 
parasympathetic innervation. Thus, by quantifying sweating via skin conductance 
measurements, we can explore another index of parasympathetic and sympathetic 
activity16,17.  
2.2 Heart Rate Variability 
Heart rate variability (HRV) has been identified as one of the best non-invasive 
tools to measure real-time autonomic activity.18  However, measuring heart rate 
variability can be difficult. Multiple external and internal factors can contribute to 
variations in heart rate such as breathing, movement, stress and even lack of sleep. 
HRV has been described as the fluctuation between intervals in both consecutive 
and instantaneous heart beats.19 Both divisions of the nervous system work to establish 
the rhythmic nature of the cardiac cycle. The parasympathetic decreases heart rate, 
while the sympathetic increases it. Since 1981, power spectral analysis has been 
utilized to quantify heartbeat oscillation (R-R) intervals. Additionally, statistically 
determined differences between R-R intervals suggest that there is some correlation to 
frequency fluctuations.18,19 HRV is an indicator of sympathetic and parasympathetic 
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activity via a power spectral analysis through three main frequency components: (1) low 
frequency (LF), high frequency (HF) and (3) very low frequency (VLF). High frequency 
(HF) values indicate parasympathetic activity (0.15-0.4 Hz), while low frequency values 
(0.4-0.15 Hz) indicate sympathetic activity, specifically when expressed in normalized 
units15. Figure 1 shows the low frequency and high frequency components of heart rate 
with its corresponding ranges for sympathetic and parasympathetic activity.20 Very low 
frequency values (<0.04 Hz) are believed to signify sympathetic activation15. However, 
in this study, we will focus on low frequency and high frequency components. 
 
Figure 1. Low and high frequency components of HRV 
2.3 Photo-plethysmography  
Photo-plethysmography (PPG) is a non-invasive tool that utilizes optical based 
technology to measure the rate of blood flow generated by the heart’s pumping 
mechanism. PPG utilizes low-intensity infrared light to create the PPG waveform that 
occurs when light travels through biological tissues and is absorbed by venous and 
arterial blood. One component of the PPG waveform is a pulsatile AC physiological 
component, typically at around 1 Hz, attributed to cardiac synchronous changes in 
blood volume with each heartbeat. Such waveform is superimposed on a slowly varying 
“quasi-DC” baseline with various low frequency components associated with respiration, 
sympathetic activity, and thermoregulation.21 Although a DC component does not 
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normally vary, in the PPG waveform, there are slow changes present due to respiration, 
vasomotor activity, vasoconstriction waves, and thermoregulation21.  
Moreover, the AC component has smaller amplitude than the “quasi-DC” 
component. The absolute maximum of the AC component is associated with systolic 
blood pressure, while the relative maximum is associated with diastolic blood pressure. 
Systolic blood pressure is related to the contraction of the heart with each heartbeat that 
forces blood out through the arteries to the entire body. Diastolic blood pressure refers 
to the pressure created when the heart is at rest between heartbeats. During this 
process, the heart is filled with blood.22 The instantaneous heart rate is the time 
difference between two consecutive systolic peaks. In this study, PPG is used to 
measure heart rate variability – the variation in the beat-to-beat interval. 
 
2.4 HRV Live Software 
HRV Live! is a software developed by Biocom technologies that relies on photo-
plethysmography (PPG) to measure heart rate variability. It allows for the measurement 
of parasympathetic and sympathetic activity in real time as well as calcuating root mean 
squared standard deviation (RMSSD) and standard deviation from normal to normal 
(SDNN). This software automatically transforms the PPG signal to heart rate in beats 
per minutes using an algorithm that measures the pulse wave to derive beat-by-beat 
intervals (P-P). Then, it performs a power spectral analysis using a Fast Fourier 
Transform (FFT) to extract data from the power spectrum (i.e. the low frequency and 
high frequency values associated with parasympathetic and sympathetic inputs, 
respectively) as well as very low frequency, total power, and the LF/HF ratio23.  
2.5 Anatomy, Physiology, and Properties of the Skin 
The interpretation of skin conductance requires a basic understanding about the 
structure of tissues and the electrical properties of the skin. Skin can be broken down 
into three main layers: the epidermis, the dermis, and subcutaneous tissue. The 
outermost layer, the epidermis, is composed of the stratum corneum, the stratum 
lucidum, the granular layer, the prickle cell layer, and the basal (germinating) layer. The 
epidermis is a renewing layer that contains derivative structures including finger and toe 
nail.  The dermis is the layer of skin between the epidermis and the subcutaneous 
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tissue that contains blood vessels, capillaries, nerve endings, and eccrine sweat glands. 
Sweat production by the eccrine glands is stimulated via cholinergic fibers from the 
sympathetic nervous system. The eccrine sweat glands secrete a hypotonic solution to 
plasma with varied amounts of electrolytes such as sodium, chloride, and potassium; 
therefore, sweat is a relatively good conductor, considered to be equivalent in 
conductance to 0.3% NaCl salt solution24. As sweat production increases, the excretory 
ducts of the eccrine sweat glands composed of epithelial cells fill.17 
2.6 Electrodermal Activity  
Electrodermal activity (EDA) is an umbrella term that refers to autonomic 
changes in the electrical properties of the skin.25 One property, skin conductance, can 
be quantified by applying an electrical potential between two points of skin contact and 
measuring the current flow between them. Skin conductance data is composed of a 
sequence of overlapping phasic responses over a tonic component. Thus, the EDA 
complex can be distinguished between background tonic skin conductance level (SCL) 
and rapid phasic components, known as skin conductance responses (SCR) that result 
from sympathetic activity.24,25  Figure 2 contains an overview explaining electrodermal 
activity, its tonic and phasic components, and the information that can be extracted from 
each.  
In addition, electrodermal activity can be divided into two types of measurements: 
exosomatic, which refers to current that is introduced from the outside, and 
endosomatic, which refers to an internal voltage source.  




Figure 2.Breakdown of electrodermal activity including its tonic and phasic components 
Electrodermal activity is commonly measured at palmar sites using Ag/AgCl 
electrodes with specific placement sites. Each electrode contains a half-cell potential; 
therefore, if the potentials are similar and contain the same chloride concentrations, 
their effects are equal and cancel. Thus, to prevent this, it is best to use an electrode 
paste with the same salt concentration of sweat such as 0.3% NaCl. Abrasion of the 
sites reduces resistance and noise, thus providing a clear waveform.24 Moreover, since 
this is a reversible type of electrode, polarization and bias potential are minimized.  
To measure exosomatic conditions, two different conditions can be used: either a 
constant current or a constant voltage. For constant-current conditions, Equation 1 is 
used to measure skin conductance as a function of time (SC (t)), where Eb = battery 
voltage, RA= series resistance, and Vs = voltage source. 
                                           𝑆𝐶(𝑡) =
𝐸𝑏
𝑅𝐴𝑉𝑠(𝑡)
                              Equation 1 
For constant-voltage conditions, Equation 2 is used to measure skin resistance as a 
function of time (SR (t)), where RA = series resistance and it is small compared to RS = 
resistance of skin, and voltage VA = voltage measured across the resistance.  
                                          𝑆𝑅(𝑡) =  
𝐸𝑏𝑅𝐴
𝑉𝐴
                       Equation 2 
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2.7 Skin Conductance  
Sudomotor function testing measures the function of sweat gland innervation. It 
evaluates the peripheral sympathetic nervous system but relies mainly on cholinergic 
post-ganglionic neurotransmission due to the innervation with the secretory portion of 
the sweat glands. Through this process, the sweat is released into the sweat duct 
leading through the dermis and epidermis, and concluding in a pore located on the 
skin’s surface. One skin conductance response (SCR) corresponds to a single 
sudomotor burst. The skin conductance signal is composed of slow varying tonic levels 
superimposed by separate phasic skin conductance responses16,26.  
2.7.1 Consensys Software 
Consensys software interfaces with the Shimmer 3 Galvanic Skin Response + 
Unit (Dublin, Ireland) to collect skin conductance data. It allows for live data collection, 
data processing (e.g. digital filters), and mathematical algorithms.  
2.7.2 Shimmer 3 Galvanic Skin Response + Unit 
The Shimmer 3 Galvanic Skin Response (GSR)+ Unit contains an internal 
resistor network which works as a potential divider, thus providing a voltage that can be 
converted by an internal analog-to-digital converter (ADC) to a 12-bit number. This 
number represents the external skin conductance. Using the values obtained from the 
12-bit ADC, the Shimmer 3 reports values from 0 to 4095 which are proportional to skin 
conductance. Then, each full-scale range setting is mapped to a linear function used to 
calculate the skin conductance value per Equation 3, where x equals the ADC output, y 
equals skin conductance (µS), and p1 and p2 are parameters specific to the range 
setting determined by the two most significant bits of the Shimmer output. These 
parameters are shown in Table 1.27 
                              𝑦 = 𝑝1𝑥 + 𝑝2                                          Equation 3 
Typically, conductance value output is measured in Siemens, thus resistance in 
ohms is determined by Equation 4. Tables 2 and 3 contain the typical physiologic skin 
conductance values on healthy adults as well as the range of the Shimmer 3 GSR+ 
Unit. 
                       𝑅𝑒𝑠𝑖𝑠𝑡𝑎𝑛𝑐𝑒 (𝛺) =  
1×106
𝐶𝑜𝑛𝑑𝑢𝑐𝑡𝑎𝑛𝑐𝑒
                              Equation 4 
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Table 1. Coefficients for ADC value to skin conductance conversion. 
Setting Full Scale Range Linear 
Coefficients Resistance Conductance 
0 10 kΩ - 56 kΩ 100 µS – 17.9 µS p1 = 0.0373 
p2 = - 24.9915 
1 56 kΩ - 220 kΩ 17.9 µS – 4.5 µS p1 = 0.0054 
p2 = - 3.5194 
2 220 kΩ - 680 kΩ 4.5 µS – 1.5 µS p1 = 0.0015 
p2 = - 1.0163 
3 680 kΩ - 4.7 MΩ 1.5 µS – 0.2 µS p1 = 4.558×10-04 
p2 = - 0.3014 
 
Table 2. Skin resistance physiologic values and detection range from the Shimmer 3 GSR+ 
Unit.27 
Skin Resistance Values 
Typical Physiologic Resistance Range 47 kΩ – 1 MΩ 
Shimmer’s Resistance Detection Range 10 kΩ – 4.7 MΩ 
 
Table 3. Skin conductance physiologic values and detection range from the Shimmer 3 GSR+ 
Unit.27 
Skin Conductance Values 
Typical Physiologic Conductivity Range 21 µS – 1 µS 
Shimmer’s Conductivity Detection Range 100 µS – 0.2 µS 
2.7.3 Skin Conductance Signal Decomposition  
The decomposition of skin conductance data by means of deconvolution was 
proposed by Alexander et al, in which he argued that the skin conductance data was a 
result of a convolution process of the activity of sudomotor nerves which corresponds to 
a driver function as well as an impulse response shaped similar to a biexponential 
function. It was proposed that deconvolving skin conductance data by the response 
function, conforms to a sequence of discrete bursts. Then, peak detection was 
performed on the drivef runction and time segments can be extracted from this. Lastly, 
isolated skin conductance responses (SCRs) can be extracted from the original skin 
conductance data with a reconstructed signal, for which the respcted segment is set to 
baseline. After isolation of the skin conductance responses, then phasic parameters can 
be computed from each single, non-overlapped SCR 34.   
LEDALAB is a MATLAB-based software for the analysis of skin conductance, 
specifically its decomposition into phasic and tonic components. Decomposition of skin 
   
10 
 
conductance data requires a two-compartment diffusion model to describe the shape of 
the skin conductance responses based on sweat diffusion as well as a method of non-
negative deconvolution to decompose the data into its tonic and phasic components. 
LEDALAB performs “event-related analysis” – analysis in which stimuli is applied – and 
returns various parameters of phasic and tonic activity via continuous decomposition 
analysis (CDA), a method in which skin conductance data is decomposed into 
continuous signals of phasic and tonic activity.  
Skin Conductance Responses (SCRs) are described by the following 
biexponential function:  






𝜏2)    Equation 5 
However, biexponential functions can be derived directly from models of the 
dynamics of the concentration of sweat in the corneum. This can be modeled by a two-
compartment model in which the sweat is released to compartment A – the sweat duct – 
then travels to compartment B – the corneum – and is evaporated from compartment B. 
In this model, it is assumed that diffusion and evaporation occur in a unidirectional 
manner at a speed proportional to the concentration in its respective compartment. It is 
also assumed that compartment B is much larger than compartment B so that 
unidirectional diffusion can occur. Such dynamics are derived from two coupled first-
order differential equations describing the concentration of sweat in the compartments A 
and B: 















                    Equation 6 
Since it is assumed that diffusion can only occur unidirectional (forward) this 
grants a stepwise solution, entering the solution of the previous compartment in the 
equation for the next compartment26. Furthermore, using the biexponential function, the 
skin conductance time-series was modeled: 
                      𝑞(𝑡) = (𝜏0𝜏1)
𝑑2𝑦
𝑑𝑡2
+ (𝜏0 + 𝜏1)
𝑑𝑦
𝑑𝑡
+ 𝑦(𝑡)               Equation 7 
In this equation, 𝜏0 𝑎𝑛𝑑 𝜏1 are time-constants, while y (t) = skin conductance, and 
q (t) = the driver function. An impulse spike in the driver at t = 0, results in the Bateman 
Function28: 
   
11 
 






𝜏2                                 Equation 8 
The Bateman function is described by a steep onset (𝜏1) and a slow recovery 
(𝜏2). Thus, the skin conductance model equation defines the signal y (t) as the 
convolution of the driver function q(t) with a biexponential function. Therefore, by 
deconvolving the signal, the driver function can be acquired, allowing the isolation of the 
individual peaks. After the peaks have been isolated, the peaks can then be 
deconvolved with the biexponential function to reconstruct individual skin conductance 
responses, thus giving rise to the phasic and tonic components of the signal.  
Since the standard deconvolution requires the assumption of a standard SCR 
shape (impulse response), this means that it cannot account for different SCR shapes 
as they may result from the conditional process of pore opening. Therefore, the 
deconvolution method used in LEDALAB, deconvolves the data by a fixed response 
function which is the Bateman function. However, this does allow for the detection of 
departures from the SCR shape.   
LEDALAB performs the non-negative deconvolution based on literature that 
assumes that skin conductance can be viewed as a result of a driver function – the 
activity of sweat glands or sudomotor neurons – which triggers an impulse response – 
skin conductance increases due to perfusion by the sweat. Since sudomotor neurons 
are supposed to be either active or inactive, then the driver function representing such 
activity, should be non-negative: either producing positive impulses or staying at zero. 
Since the signal is divided by the impulse response which generates the driver function, 
then it must also be a condition that all the values in the quotient must be non-negative. 
This can be achieved only if the entire quotient is considered where such is calculated 
per digit and the overall minimum is taken. Thus, non-negativity can be achieved while 
still performing the convolution.  
In summary, the decomposition of the signal is completed in four steps: 
“estimation of the tonic component, non-negative deconvolution of phasic skin 
conductance data, segmentation of driver and remainder, and reconstruction of skin 
conductance data”26. 
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2.8 Quantitative Sensory Testing 
The PATWHAYS CHEPS model, which is the instrument that was used in this 
study to apply a cold stimuli to subjects relies on quantitative sensory testing (QST). 
QST is a non-invasive method for diagnosing peripheral nervous system disorders 
including chronic pain and pain-related diseases such as diabetes.  QST determines the 
sensation and pain thresholds for cold and warm temperatures 33. Quantitative sensory 
testing is the most frequently used method to assess and quantify somatosensory 
function of the whole somatosensory system, from the receptors to the cerebral 
cortex.29,30,31 QST measures detection thresholds for thermal stimuli, both hot and cold 
as well as mechanical stimuli.29,30 However, for this study, only cold-thermal stimuli was 
used.  
The German Research Network of Neuropathic Pain (DFNS) has developed a 
standardized QST battery that consists of 7 tests measuring 13 parameters including: 
thermal detection thresholds for the perception of cold and warm sensations, thermal 
pain thresholds for cold and hot stimuli, mechanical detection threshold for touch and 
vibration, mechanical pain sensitivity such as thresholds for pinprick and blunt pressure, 
and pain summation of repetitive pinprick stimuli. However, this study would only adopt 
part of the standardized protocol developed by the DFNS, specifically the portion of the 
protocol regarding pain thresholds using thermal and pain detection.32–34 
The protocol established age- and gender-matched absolute and relative 
reference values from 180 healthy subjects by assessing bilateral stimuli over three 
distinct regions: face, hand, and foot. Per DFNS studies, QST parameters were region 
specific and age dependent. Pain thresholds were statistically lower in females than in 
males (p<0.01); however, thermal detection thresholds (cold and warm detection) 
demonstrated significant differences in gender, when classified by placement location of 
the thermode. In women, the higher temperature sensitivity was only significant in the 
lower limbs. Heat pain had the largest gender differences, followed by cold pain. No 
differences were found for bilateral comparisons of stimuli. For all QST parameters, 
sensitivity was higher in the face than in the foot, while the hand exhibited medium 
sensitivity.32  
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2.9 QST Pathway CHEPS/ATS Model 
The Pathway CHEPS/ATS Model has been approved by the FDA under 510(k), 
041908. The device summary and indications for use are included in Appendix A. The 
proposed study falls under the following indications for use for this device: "evaluating 
the functionality of human pain reception and transmission of sensory pathways." 
Therefore, the PATWAY model CHEPS/ATS will be used to create contact cold-
evoked potentials or small fiber-evoked potentials, in accordance with its indications for 
use. This system can be used as a tool for the assessment of objective pain perception 
via contact cold-evoked potentials and evaluate the changes in pain sensation due to 
pain stimuli, in compliance with UL-2601-1:94 which is a standard that covers the safety 
requirements for medical electrical systems to provide protection for patients and 
operators.35 
 The ATS technology allows for the delivery of fast, heat stimuli with 
predetermined temperatures that can be used to activate distinct sensory fiber groups 
with a temperature repeatability of ± 0.1 °C and absolute accuracy of 0.3°C.  Table 4 
shows the specific parameters used for the ATS model, including temperature range of 
the contact area.  
 
 
Table 4. PATHWAY Model ATS Specifications35. 
PATHWAY Model ATS Specifications 
Max 
Temperature  





55°C -10°C 8°C/s 8°C/s 
 
 
Chapter 3: Literature Review 
3.1 Heart Rate Variability  
A study titled “Non-pharmacological Intervention for Chronic Pain in Veterans: A 
Pilot Study of Heart Rate Variability Biofeedback,” by Berry et al., demonstrated that 
biofeedback training decreased subject pain scores when compared to a control group6. 
This study utilized 14 veterans, 8 that were in the treatment group, and 6 in the control 
group6. All study participants were diagnosed with chronic pain. The 14 participants 
were randomly assigned to a treatment and a control group. The treatment group 
received instruction a self-regulation technique that is known to increase HRV 
coherence in conjunction with a computer-based heart rate variability biofeedback 
(HRVB) plus standard of care for chronic pain, whereas the control group received 
standard care only. Subjects were excluded if they indicated regular use of medications 
known to affect pain perception or the autonomic nervous system two weeks prior to 
study participation. In addition, subjects that reported suffering from rheumatism, 
diabetes, traumatic musculoskeletal system damage, chronic, neurologic, and 
endocrinology syndromes as well as hypertension, coronary artery disease, substance 
abuse or obesity were not recruited. All study participants received pre-training baseline 
assessments of perceived pain levels using the Brief Pain Inventory (BPI) which is 
another pain rating scale that rates pain from 0 to 10 and asks a series of questions to 
better understand the nature of pain such as pain location. Stress levels were measured 
for all subjects using the Perceived Stress Scale (PSS) and baseline HRV assessments 
were also completed for all subjects. For the treatment group, the Quick Coherence 
self-regulation technique was explained and instructions were given on how to perform 
it. This technique involves controlled breathing and self-induction of positive or neutral 
emotional state. This technique was practiced during four biofeedback training sessions 
and followed a post-training assessment of pain, stress, and HRV using the brief pain 
inventory. It was found that the subjects in the treatment group showed significant 
increases over the baseline in coherence ratio as well as a significant reduction in pain 
ratings, stress, negative emotions, and limitation of physical activity via one-tailed t-tests 
with a significance of p<0.001. Using analysis of covariance (ANCOVA), treatment 
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effects were analyzed of the post-scores by group, using the pre-scores as covariate. 
This revealed that the treatment group was significantly lower than the control group for 
all measures of post HRVCB with a significance of p<0.05 6. 
Another study by Kang et al, entitled “Heart Rate Variability for Quantification of 
Autonomic Dysfunction in Fibromyalgia”, studied the ratio of SDNN and RMSSD as a 
parameter for autonomic nervous system function to potentially quantify subjective 
autonomic symptoms in patients with fibromyalgia18. In this study, 16 patients diagnosed 
with fibromyalgia (12 women, 4 men, ages 37-60) were recruited along with 16 healthy, 
gender and age-matched controls. All subjects in the control group reported no pain at 
the time of testing and were not taking medications such as anti-inflammatory drugs that 
may affect the results. Subjects in the treatment group were asked to fill out a 
Fibromyalgia Impact Questionnaire (FIQ) as well as a Numeric Pain Intensity Score 
(NPIS) which ranges from 0 (no pain) to 100 (most intense pain). A second visit was 
requested for patients to visit the hospital in the afternoon and to refrain from alcohol, 
caffeine, and strenuous physical activity in which HRV was recorded using a three-lead 
electrocardiogram (ECG). It was found that patients with fibromyalgia possessed 
significantly higher SDNN/RMSSD values under both normal quiet breathing and rate 
controlled breathings when compared to controls. Moreover, the difference between the 
longest and shortest R-R intervals were significantly lower in patients with fibromyalgia 
than in healthy controls18. 
Another study by Appelhans et al. entitled “Heart Rate Variability and Pain: 
Associations of two interrelated homeostatic processes” aims to better understand pain 
and pain sensitivity10. This study hypothesized that greater resting parasympathetically 
mediated HRV would predict reduced sensitivity to thermal pain in young, healthy 
adults. Fifty-nine right handed participants (37 women, 22 men) were recruited for this 
study and were excluded if they were taking any medications that may influence the 
data or suffered from chronic pain, were asked to refrain from smoking, alcohol, energy 
drinks, and caffeine 2 hours prior the study. Thermal stimuli were applied to these 
subjects on their non-dominant plate using a 14 cm × 33 cm cold plate with an 
integrated temperature controller (-10 and 70°C with an accuracy of ± 0.1°C). Baseline 
ECG measurements were collected for a 5 minute period, then the stimuli was applied 
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using the cold plate set at 4°C for 4.5 mins until they could no longer tolerate the pain. 
However, all participants were able to complete the 4.5 mins exposure. Upon 
completion, participants were asked to rate their pain (unpleasantness) using 101-point 
numerical rating scale in which 0 (no pain), 50 (moderate pain), and 100 (intense pain). 
In this study, the Acqknowledge software Biopac Systems Inc. was used to process the 
ECG data and automatically identify and calculate the RR interval series. Using an HRV 
analysis software for Windows, HRV measures were calculated including the power 
spectrum of HRV and its respective low and high frequency components. Regression 
models were completed for low frequency and high frequency HRV with the pain 
ratings. It was found that greater correlation for LF was associated with lower 
temperatures (higher thresholds) at which participants first identified noticeable pain. 
Greater LF predicted lower temperature (higher thresholds) for the onset of moderate 
pain. However, HF was not statistically significantly associated with thresholds for 
noticeable or moderate pain. Although LF and HF HRV were highly correlated in this 
sample (p<0.001), it was found that commonly employed indices fell well below 
conventional criteria10.  
3.2 Skin Conductance  
A study by Ledowski et al. entitled “The assessment of postoperative pain by 
monitoring skin conductance: Results of a prospective study,” demonstrated a 
correlation between fluctuations of skin conductance and subjective pain intensity using 
a numeric 0–10 rating scale, with zero being no pain and 10 ‘the worst pain 
imaginable’2. Table 5 shows the mean number of skin conductance fluctuations per 
second (NSCF) measured in 75 post-operative patients that underwent general, plastic, 
or orthopedic surgery.2 In this study, patients that reported a score of ≤ 3, the rating was 
repeated after 10 minutes, whereas patients with a score > 3, fentanyl – a synthetic 
opioid analgesic was administered intravenously, then every 3 minutes, the rating score 
was repeated until a score of ≤ 3 was achieved. A conductance (MEDSTORM AS 2005, 
manufacturer) monitor was used to measure the palmar skin conductance of these 
subjects. The mean skin conductance was calculated in microsiemens (µS) for every 5 
seconds with a refreshing rate of 15 s. Any fluctuation with an amplitude greater than 
0.02 µS was automatically counted. The number of fluctuations of skin conductance 
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was determined with a sampling rate of 1 Hz. At the same time that skin conductance 
was being measured, systolic blood pressure and heart rate were recorded. In addition, 
any data points were exclude from analysis if the patients were actively vomiting, 
shivering, or had nausea symptoms as this would cause artifacts of movement and false 
readings. In this study, at least 150 readings per group of patients with either none or 
mild pain, moderate, or severe pain. Statistically analysis were used such as the 
Spearman’s correlation coefficient (p) to describe the correlation between the number of 
skin conductance fluctuations and pain scores. However, it is important to note that the 
calculation of p does not account for variation in the number of assessments per patient. 
Pain scores were categorized as follows: none (0), mild (1-3), moderate (4-5), and 
severe (>5). Table 5 contains the results of this study in which 73 patients (30 female, 
43 male, ages 19-81, were included in this study. Two patients were not included 
because they previously received intra-operative anticholinergic drugs2.  
 
Table 5. Mean number of skin conductance fluctuations per second (NCSF) based on self-
reported pain levels on 73 post-operational subjects (*p<0.001).2 






Although, the study did find differences in the number of NCSFs, the location of 
the pain on the tested population was varied. Data included 42 orthopedic, 16 plastic, 
and 15 general surgical cases which was collected after 8.5 minutes (on average) of 
being in the recovery room.2  
Such variations in the type of surgery and differences in procedures may have 
impacted the data collected. Other factors that may influence the data include the extent 
of surgery, the reason for surgery, and the amount of anesthesia. After only 8.5 minutes 
in the recovery room, subjects may still be under the influence of anesthesia and may 
not be completely coherent, leading to inaccurate self-reported pain levels. Moreover, 
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the study failed to collect any demographic data on subjects such as weight, height, 
race as well as any history of medical diseases which may or may not influence the 
readings. It may also be the case that subjects with dry skin or sunburnt skin may have 
had different variations in skin conductance, which in turn can alter the readings. Even 
though this publication demonstrated differences in pain levels, it seemed to be limited 
by the lack of inclusion of several important factors that may affect the data.  
Another study by Gunther et al. entitled “Palmar skin conductance variability and 
the relation to stimulation, pain and the motor activity assessment scale in intensive 
care unit patients” as sympathetically mediated palmar skin conductance variability is 
related to emotionally induced perspiration and correlates with pain levels in the 
perioperative setting but had not being studied in ICU patients9. This study recruited 40 
critically-ill patients above 17 years of age, where half of the patients were intubated 
and the other half were not. Patients were excluded if they suffered from any neuro- or 
myopathy disorders, if they were on neuromuscular blocking agents or if they were 
treated with atropine or glycopyrrolate on the same day of testing as any of these could 
affect sweat gland receptor activity. Skin conductance variability was measured for a 
period of 1 hour using the MED-STORM Pain Monitoring System® on the subjects’ non-
dominant hand. Similarly to the study by Ledowski et al., any skin conductance readings 
with an amplitude greater than 0.02 µS was considered a skin conductance fluctuation. 
The mean NCSF value was calculated every 15 seconds. The refreshing time (the time 
a new window was analyzed) was one second. For patients that were awake, their pain 
level was measured using an 11-point numeric rating scale (0-10). However, for patients 
that were unable to communicate, the patient’s behavior (i.e. physical cues) at rest vs. 
during the procedures, were observed. In this study, observation of pain was done 
during the following procedures: needle stick, turning of the patient, suction of the 
mouth, unsynchronized breathing pattern with ventilator or abnormal breathing, and 
dressing of wounds. High pain were considered to be a score greater than 3; however, if 
a patient was unable to communicate, the following physical cues were considered: 
facial grimacing, moaning or groaning, withdrawing from touch or resisting potentially 
painful movement or procedure. In addition to collecting skin conductance data, 
patient’s arousal or agitation levels were measured using a Motor Activity Assessment 
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Scale (MAAS). MAAS contains a description of the person’s behavior which the 
researcher makes an observation that matches with that person’s behavior and scores 
them accordingly. For example, a score of 0 means that the patient is unresponsive and 
does not move with noxious stimuli, whereas a score of 6 means that the patient is 
dangerously agitated or uncooperative. Since intubated patients could not speak and 
more often received sedatives or opioids, the intubated patients and the non-intubated 
patients were analyzed separately. It was found that non-intubated patients displayed 
higher levels of stimulation/pain were associated with higher number of skin 
conductance fluctuations per second for all MAAS levels, except MAAS 2. In contrast, 
for intubated patients, increasing stimulation/pain was also associated with higher 
number of skin conductance fluctuations per second for all MAAS levels. It was found 
that in critically ill patients, the number of skin conductance fluctuations per second may 
be more useful to determine emotional distress than just level of pain9.  
Another study by Loggia et al, entitled “Autonomic responses to heat pain: Heart 
rate, skin conductance, and their relation to verbal rating and stimulus intensity” to 
assess the pain subjects are experiencing in an effort to quantify pain in a more 
subjective manner36. In this study, a total of 39 male subjects between the ages of 19 
and 34 were recruited. Stimuli were applied using the CHEPS PATHWAYS Model in 
which all subjects received a 12 heat stimuli (4 temperatures: 42 °C, 44 °C, 46.5 °C, and 
48 °C; 3 repetitions per temperature), which were pseudo-randomly applied on three 
regions of the left volar forearm. Each stimuli lasted 6 seconds and was applied 34 s 
after the previous one. Four seconds after the end of each stimulus, the thermode was 
removed from the skin, and subjects were asked to numerically rate the heat intensity 
and unpleasantness using a 200-mm Visual Analogue Scale (VAS) as a reference. Pain 
was ranked as 0 (no pain) and most intense pain tolerable (200). Skin conductance was 
recorded in micro-Siemens (µS) and at a sampling rate 32 Hz using 2 circular 
electrodes. Heart rate was also measured in beats per minutes (BPM) using an 
electrode placed under each clavicle and 1 electrode below the sternum at a sampling 
rate of 4 Hz.  The coefficients of the within-subjects correlations between the intensity 
ratings and autonomic responses were calculated. A paired sample t-tests within-
subjects revealed that the coefficients for the correlations between intensity ratings and 
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%SC were significantly higher than those for the correlations with %HR when all stimuli 
were analyzed. Although a few subjects exhibited negative correlations between pain 
ratings and heart rate, none reached statistical significance. In a few subjects, 
correlations with %HR or %SC were negative (statistically significant in 1 subject for SC, 
P < .01, and trending toward significance in another subject for HR, P = .08). Repeated-
measures ANOVA on the coefficient of variations were completed for temperature × SC 
and temperature × Heart Rate, which yielded statistically significant results for both. . 
Post hoc pairwise comparisons revealed that the correlation variation for %HR were not 
statistically different across temperatures. However, for %SC at the 2 highest 
temperatures were statistically smaller than both those at the 2 lowest temperatures 
than those of %HR at all temperatures. It was found that graded intensities of painful 
cutaneous heat stimuli evoke graded increases in both heart rate and skin conductance. 
Within-subject analyses revealed higher and less scattered R values for the correlations 
with skin conductance, suggesting that SC is more sensitive to relative changes in 
perception. Despite the stronger within-subject correlations, at the group level SC did 
not significantly correlate with each subject’s pain rating, suggesting that this measure 
does not predict the absolute level of pain reported by the subject. However, the heart 
rate data showed the exact opposite pattern: even though %HR did not reliably predict 
verbal responses to pain stimuli on a trial-by-trial basis, it did at the group level. The 
researchers argue that the incongruity between within- and between subjects analyses 
suggests that HR, although genuinely affected by pain perception (between-subject 
analyses), is a very noisy measure, requiring averaging over several stimulations in 
order to yield reliable responses36. In this study, both heart rate and skin conductance 
were significantly increased during pain which confirms a wide range of previous studies 
that have observed this relationship with either heart rate, skin conductance, or both, 
using experimental heat pain37,38,39,40,41.  
However, some studies have examined both skin conductance and heart rate in 
response to pain, and results of these studies are variable. Some found greater 
increases in skin conductance, others found stronger effects for heart rate and some 
find similar changes for both measures; however, most studies did not include pain 
ratings.  
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3.3 Cross-Correlation  
A study titled “Nonlinear relationship between electrodermal activity and heart 
rate variability in patients with acute schizophrenia” by Rachow et al.17, found a non-
linear relationship between electrodermal activity and heart rate variability in patients 
with acute schizophrenia. This study aimed to test the hypothesis that heart rate 
modulation and electrodermal activity (EDA) is more closely interrelated in patients with 
schizophrenia as compared to healthy controls. Eighteen patients with paranoid 
schizophrenia were recruited along with matched controls (age, sex, weight, smoking 
habits, and education level). Patients were excluded if they suffered from any other 
psychiatric or somatic diseases and if they were on any medication that could affect the 
readings. Psychotic symptoms were quantified using the Scale for the Assessment of 
Positive Symptoms (SAPS), the Scale for the Assessment Negative Symptoms (SANS), 
and the Positive and Negative Symptom Scale (PANSS). To measure the interrelations 
between heart rate variability and skin conductance level (time series), HRV and skin 
conductance level (SCL) were being recorded at the same time using the same device 
(LifeShirt System™ – a garment with embedded sensors that continuously collects 
information on a range of cardiopulmonary parameters, including HRV, GSR, 
temperature etc.) Both HRV and SCL were measured for 30 mins after subjects had 
rested in a supine position for 10 minutes. This device automatically extracted beat-to-
beat intervals using PPG and SCL was measured using seat-isotonic records placed on 
the palm of subjects. RMSSD, HF Norm and LF Norm were measured for HRV, 
whereas skin conductance level was measured for skin conductance. Using a 
Multivariate Analysis of Variance (MANOVA), it was revealed that there was a 
significant difference overall between patients and controls for heart rate, RMSSD, LF 
Norm, HF Norm, and SCL.  
Although other cross-correlation studies have been done, to my knowledge, this 
is the only study that has cross-correlated heart rate variability with skin conductance. 
Even though in this study electrodermal activity and heart rate variability were 
correlated, there was no pain stimulus included as part of the study Therefore, this 
study did not rely on pain scales, and instead, positive and negative symptoms were 
measured on patients with schizophrenia. It was hypothesized that un-medicated 
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patients with schizophrenia contain more interrelation in comparison to controls (no 
schizophrenia), due to reduced parasympathetic cardiovascular regulation.11 However, 
some limitations of this study include: a small sample size, uncontrolled breathing rates, 
and using two different devices to assess skin conductance. Nevertheless, this study 
strengthens the proposed hypothesis that there is a relationship between heart rate 




Chapter 4: METHODS 
4.1 Objective 
The overall objective of this research is to identify a relationship between two 
established measures of pain: heart rate variability and skin conductance, using a 
cross-correlation analysis when pain stimuli are applied to healthy college students. To 
perform the cross-correlation analysis, the skin conductance data must be decomposed 
into its tonic and phasic components via the non-negative deconvolution. Once the 
phasic and tonic components were extracted from the skin conductance signal, they 
were cross-correlated with the high frequency and low frequency components of the 
heart rate variability signal, respectively.  
Identifying a relationship between these two signals can have potential uses such 
as creating a more powerful tool used to treat chronic pain non-pharmacologically, 
through biofeedback training as well as improving the accuracy of pain reporting 
techniques.  
4.2 Subject Inclusion and Exclusion Criteria  
Data were collected from nineteen male and female college students, ages 19-32.  
Only data for 17 subjects were used because one file was corrupted, and one subject’s 
data was too noisy to use. The subjects acted as self-controls with readings taken 
before and after the stimuli. The study subjects were selected based on the absence of 
previous known chronic pain diseases. All subjects were physically healthy and had no 
known symptoms of chronic pain. All subjects were proficient in the English language. 
The principal investigator assessed such criteria for inclusion; all students invited to 
participate met the specified criteria. No special populations were considered for this 
study.  
4.3 Subject Recruitment and Consent 
The study subjects were recruited from East Carolina University in Greenville, NC. A 
consent form was provided to each participant (see Appendix B). The study subjects 
were identified and recruited by the principal investigator and/or the co-investigator 
through the following avenues: verbal, email, or flyer invitation. A detailed consent form 
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was provided upon agreement to participate in the study stating that participation in this 
study was voluntary, confidential and that all results will be kept in a locked cabinet in 
Austin Hall, Room 321 for at least three years. All subjects were rewarded with $15 gift 
cards for their participation. 
4.4 Study Location  
Subjects participated in this research study in Rose Hall 2150. Subjects were 
exposed to the same environment and the same equipment. While at the study location, 
subjects were not exposed to any type of audio-visual stimuli that may had influenced 
their heart rate or skin conductance. Approximately 4- 6 hours before the study, 
subjects were asked not to consume energy drinks, caffeine, or consume medications 
that may induce tachycardia. Subjects were exposed to the same environmental stimuli 
or no stimuli at all (e.g. room temperature, visual or audio stimuli etc.)  
4.5 Procedure  
 
Figure 3. Procedure Overview 
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4.5.1 Cleaning and Disinfecting 
Since the same room and equipment were used for data collection, the hardware 
was wiped down with alcohol wipes before and after each subject. The chair were 
subjects were sitting was wiped with Cavi Wipes™ disinfecting towelettes and a plastic 
chair cover was changed after every use. The principal investigator changed gloves 
after every subject and wiped down counter areas where their hands or personal 
belongings were placed using isopropyl alcohol (IPA).  
4.5.2 Pre-Screening Survey 
An initial screening survey was done to collect demographic information (see 
Appendix C), screen participants, and to verify that the subjects did not suffer from any 
chronic pain and meet age criteria. We did not screen for acute pain as this study only 
pertains to chronic pain. A separate post-test survey (see Appendix D) was 
administered to identify their pain intensity after the stimulus, using the defense and 
veteran’s pain rating scale (DVPRS). The DVPRS was used for two reasons: first, it is a 
pain assessment tool that combines a numerical rating scale, word descriptions, color 
coding, and pictorial facial expressions all matched to pain levels which appeal to a 
wide variety of individuals. Second, the DVPRS has shown to be consistent and 
reliable.42 
The principal investigator provided the subject with all the necessary information 
regarding the study, including disclosure of risks. Upon agreement to take part in the 
study, the subject was provided with a consent form and the consent form was reviewed 
and stored by the principal investigator. A copy of the consent form was given to each 
participant for their records. Each subject’s identifiable information was kept 
confidential. A feasibility study was done in which only baseline data was collected 
under UMCIRB 17-000602. The purpose of this feasibility study was to test out the 
procedures and equipment so that any adjustments regarding data collection 
mechanisms could be made. Data from the feasibility study was not included in this 
document. Data for this study were collected under UMCIRB 17-001152 (Appendix C). 
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4.5.3 Data Collection 
First, nineteen college students were pre-screened to verify that they do not 
experience any type of chronic pain. Second, the subjects were asked to sit in an 
upright position on a chair and to try to minimize movement. Then, the principal 
investigator placed the HRV monitor (Biocom pulse wave sensor HRM-02, Poulsbo, 
WA) on the subject’s right earlobe. Figure 4 shows the correct placement of the ear lobe 
sensor. The GSR hardware (SHIMMER 3 GSR + Unit, Dublin, Ireland) consists of two 
sensors that are fastened with Velcro to the subject’s index and middle fingers. Figure 5 
shows the correct placement of the GSR hardware. 
 
Figure 4. Ear lobe sensor positioning for optical pulse measurements 




Figure 5. Correct GSR electrode positioning 
To obtain baseline measurements, data were collected for five minutes on each 
subject. Pain was not measured at baseline as no pain stimuli were induced during this 
time. After baseline readings for heart rate and skin conductance were established, 
stimuli were applied using the MEDOC PATHWAY CHEPS Model. Subjects were 
informed in the consent form of the temperature limits of the probe to avoid any type of 
fear of injury during testing.  
The thermode of the MEDOC PATHWAY CHEPS model was placed on the subjects’ 
forearms, in accordance with the German Research Network of Neuropathic Pain 
(DFNS) protocol. For this experiment, we used cold stimuli, starting at 37°C, which is 
normal physiologic temperature, and decreased the temperature at a rate of 0.33°C/s, 
until the subject experienced pain or the probe reached 0°𝐶. Subjects were provided 
with a reset button on their contralateral hand and were instructed to press the button as 
soon as they perceived any pain within the specified categories (mild, moderate, or 
severe pain). At reset, the probe temperature returned to 37°C. The average 
temperature that all subjects experienced overall for all categories was 25.7 (± 3.6). A 
secondary safety mechanism was established in case the button failed which involved 
the temperature to be reset in the software itself by the test operator; however, this was 
not used in data collection as the reset button did not fail. Tests for pain intensities were 
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repeated 3 times, one for each pain category — mild, moderate, or severe, during an 
approximate 6-minute period.  
Meanwhile, heart rate variability and skin conductance were collected continuously 
at a sampling rate of 1 Hz; after the baseline was established, during the stimuli, and 
after the stimuli for a total of approximately 17 minutes per subject, during a one-time 
visit. Figure 6 contains the correct placement of all hardware. Then, the principal 
investigator removed all hardware from the subject’s body. During data collection, the 
subjects were asked to complete the Defense and Veterans Pain Rating Scale 
(DVPRS) by telling the principal investigator the pain number they were currently 
experiencing.43  
 
Figure 6.Correct placement of all hardware on subject 
4.6  Risks 
There were only minimal risks associated with participation in this research. The 
Shimmer™ GSR + Unit and the PPG optical sensor utilize non-invasive techniques to 
assess electrodermal activity and heart rate variability, respectively. Minimal side effects 
may be associated with using thermal testing, including goosebumps and temporary 
skin redness. The PATHWAY CHEPS/ATS model has built-in safety features that do 
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not allow for the maximum temperature to go over 55 °C or its minimum temperature to 
fall below -10°C. However, none of the subjects reported experiencing any side effects. 
Subjects were told prior to the study that they may stop participating at any time.  
4.7 Confidentiality 
The records of this study were kept confidential. The principal investigator did not 
include the name of any participant involved in this research in any scientific reports. 
Research records were kept in a locked file in Austin Hall, Room 321 at East Carolina 
University. The principal investigator and the co-investigator will be the only persons 
who will have access to these records. 
4.8 Sample Size Calculation 
Sample size was calculated with Minitab® Statistical Software, using the ‘sample 
size for estimation’ method. Data from Gunther et al. was used to calculate this sample 
size estimation for skin conductance, specifically, the results from “Table 2: Patient 
demographics” which include 60 intubated patients with a standard deviation of 16 and 
55 non-intubated patients with a standard deviation of 18.2 The sample size for 
estimation was calculated with the largest sample size based on literature which was 
18, an assumed margin of error of 10, and a two-sided confidence level of 95% which 
resulted in a sample size of 15 subjects. Figure 7 contains the sample size estimation 
for skin conductance from Minitab® Statistical Software. Similarly, the sample size 
needed for heart rate variability was calculated using the same method with the data 
from Appelhans et al., specifically, the 4°C pain intensity mean of 52.36 with a standard 
deviation of 19.65 in a pool of 59 subjects.10 This data was used since this study utilized 
a similar procedure in which pain was induced to subjects via the cold pressor test, 
while collecting HRV data. Figure 8 contains the sample size estimation for heart rate 
variability from Minitab® Statistical Software. As a result, the proposed sample size for 
this study is a minimum of 18 subjects. 




Figure 7. Sample Size Estimation for Skin Conductance using Minitab Statistical Software. A 
margin error of 10 was assumed for this calculation.  
 
 
Figure 8. Sample Size Estimation for heart rate variability using Minitab Statistical Software. A 




Chapter 5: Data Processing and Analysis 
5.1 HRV in Time domain 
 The common measures of heart rate variability were compared such as SDNN 
(standard deviation of NN intervals) and RMSSD (root mean squared standard deviation 
of consecutive NN intervals).  
5.2 HRV in Frequency Domain 
The low frequency (LF norm) and high frequency (HF Norm) normalized values 
were extracted from the HRV Live! Software. These values were then graphed in 
MATLAB for both pre- and post- stimuli as a function of time for all subjects. 
Table 6. Data Groups and Conditions 
Group Condition 
LF Norm pre Low frequency values of HRV at rest (before 
the cold stimuli) 
LF Norm post 1 Low frequency values of HRV during the 
first cold stimuli range (mild pain). 
LF Norm post 2 Low frequency values of HRV during the 
second cold stimuli range (moderate pain). 
LF Norm post 3 Low frequency values of HRV during the 
third cold stimuli range (severe pain). 
HF Norm pre High frequency values of HRV at rest 
(before the cold stimuli) 
HF Norm post 1 High frequency values of HRV during the 
first cold stimuli range (mild pain). 
HF Norm post 2 High frequency values of HRV during the 
second cold stimuli range (moderate pain). 
HF Norm post 3 High frequency values of HRV during the 
third cold stimuli range (severe pain). 
SC tonic pre Skin conductance tonic component at rest 
(before the cold stimuli)  
SC phasic pre Skin conductance phasic component during 
the first cold stimuli range  
SC tonic post Skin conductance tonic component during 
the second cold stimuli range 
SC phasic post  Skin conductance phasic component during 
the third cold stimuli range 
*Note: All data groups were collected for all subjects individually, yielding 12 variables per person, 
for a total of 204.  




5.3 Skin Conductance Data 
 
Figure 9. Skin Conductance Data Analysis Overview 
Figure 9 contains an overview of the data processing procedure used. After data 
collection, all pre- and post- stimuli skin conductance data were modified to convert 
from EPOCH time to a regular time format (i.e. dd:mm:yyyy:hh:ss.0) as well as convert 
GSR calibrated data to skin conductance using Equation 4. In addition, all time points 
were added to these files manually to reflect the (events) in which a stimulus was 
applied. Then, all excel data files were loaded into MATLAB using an original script in 
which pre- and post- stimuli data were separated. This MATLAB original script was then 
used to interface with LEDALAB to separate the tonic and phasic components of the 
skin conductance signal.  
5.3.1 Event Detection 
 LEDALAB necessitates the user to input the time points in seconds in which the 




in seconds in which the stimuli were applied (referred to as events) along with the event 
ID (i.e. 1, 2, 3) were created for all subjects. Each plain text file was imported into 
MATLAB along with the corresponding excel file that contained the skin conductance 
data for each subject. Due to the nature of event time collection which consisted of 
writing down the time relative to the start of data collection when a subject pressed the 
reset button, the exact time may or may not be correct. Each person’s reaction time 
needs to be accounted for as well as the reaction time of the principal investigator; thus, 
some time events were off by just a few seconds. Thus, the principal investigator 
visually inspected the signals to ensure that the time event was at the peak of the 
signal, if not, then the event time was altered to accommodate such. 
5.3.2 Separation of Phasic and Tonic Components  
 Upon event detection, the data was optimized to improve the goodness of fit of 
the model as the decomposition procedure is initially implemented with predefined 
parameters for 𝜏1 and 𝜏2 (𝜏1 = 0.75, 𝜏1 = 0.20). Optimization of data re-runs all four 
steps of decomposition (i.e. i) estimation of the tonic component, ii) non-negative 
deconvolution of phasic skin conductance data, iii) segmentation of driver and 
remainder, and iv) reconstruction of skin conductance data26) with the new parameters. 
To decompose the signal into its tonic and phasic components, a standard 
deconvolution is applied to the signal using the Bateman function. As the impulse 
response is computed, it concludes with an estimation of the driver function that is not 
non-negative, producing only a tonic skin conductance component. Via a convolution, 
the resulting driver function was smoothed with a Gaussian window since deconvolution 
amplifies noise. Once the driver function was smoothed, the peaks were detected to 
identify individual impulses. Peak detection was computed by finding zeros in the first 
time-derivative of the smoothed driver function. Local maxima and minima were found. 
An impulse is defined by the section between the local maxima and minima and a 
significant peak is defined as having a difference of 𝛿 ≥ 0.2 𝜇𝑆. Lastly, “tonic activity is 
estimated using a time grid with 100 s spacing by averaging the driver function of inter-
impulse sections within the range of half of the grid spacing before and after the grid 
points”. Upon tonic signal estimation, the signal was subtracted from the raw skin 




screenshot of subject 4, during optimization, smoothing, continuous decomposition 
analysis, and peak detection. Figure 11 shows the resulting plot after applying the 
continuous decomposition analysis seen on Figure 10 which yields the phasic (blue) 
and tonic (gray) skin conductance components in an interactive plot.  
 
Figure 10. Continuous Decomposition Analysis in LEDALAB 





After the phasic and tonic activity were extracted from the time domain signal of 
skin conductance, the values were extracted from LEDALAB and plotted using an 
original MATLAB script. However, it was observed that the signals would just drop off 
after a certain point. It was found that the plots had two zero values at the end that 
would greatly influence the correlation; therefore, these values were removed and only 
array values with a numerical value greater than zero were used. These zero values 
were on every subject’s last two data points and were attributed to taking off the 
hardware (i.e. the PPG sensor and the SHIMMER 3 GSR+ Unit) from each subject 
before stopping data logging. Figure 12 shows the phasic and tonic values from subject 




Figure 12. Sample Decomposed Skin Conductance Signal in its Phasic and Tonic Components 





Figure 13. Sample Decomposed Skin Conductance Signal in its Phasic and Tonic Components 
without the zero values. 
5.4. Cross-Correlation Analysis 
First, all conditions (HF Norm pre, HF post- stimuli 1,2, and 3, LF Norm pre, LF 
post- stimuli 1,2, and 3, tonic pre- and post- stimuli, phasic pre- and post- stimuli) were 
normalized by subtracting their mean away from each other and dividing by its 
corresponding standard deviation. Second, the cross-correlation of heart rate variability 
and skin conductance was done for each condition using the xcorr function on an 
original MATLAB script.  Specifically, high frequency values of HRV (HF Norm) were 
cross-correlated with phasic values of skin conductance, whereas low frequency values 
of HRV (LF Norm) were correlated with tonic values of skin conductance. Equation 9 
shows the xcorr command, where r = correlation coefficient, x = signal 1, y = signal 2. 
Equation 10 is a sample normalized cross-correlation mathematical function applied to 
all subjects.  
𝑟 = 𝑥𝑐𝑜𝑟𝑟(𝑥, 𝑦)  Equation 9 
 
𝑟 =  𝑥𝑐𝑜𝑟𝑟(









The cross-correlation for each condition (for example, the cross-correlation of HF 
Norm pre and tonic pre) were plotted using an original MATLAB script. Then, the 
absolute maximum or minimum were found to determine the highest degree of 
correlation for each condition. Everything before the zero time mark was ignored and 
only regarded a peak as a maximum value after zero to be significant.  Figures 14 and 
15 show a sample cross-correlation of LF and HF, respectively. 
 










Chapter 6: Results 
6.1 Descriptive Statistics 
Data for subject 8 were unused due to a software issue that caused the skin 
conductance file to be corrupt and unable to access. Data for subject 1 were unused 
because it was too noisy and could not get any good readings out of it. Thus, all data 
analysis was done on 17 subjects, ages 19-23. Table 7 contains the descriptive 
statistics. Table 8 contains the mean pain scores of 17 subjects using the Defense and 
Veterans Pain Rating Scale.  
Table 7. Descriptive Statistics for Subjects used in Data Analysis 
Group Amount Age 
All 17 21.3 (±1.4) 
Females 12 21.1 (±1.1) 
Males 5 21.8 (±1.9) 
 
Table 8. Descriptive Statistics for Pain Scores 
Group Mild Moderate Severe 
All 2.29 (±0.85) 5.28 (±1.09) 7.29 (±1.57) 
Female 2.42 (±0.90) 5.54 (±0.66) 7.83 (±0.83) 
Male 2.33 (±1.03) 4.40 (±1.52) 6.00 (±2.24) 
*Mean pain scores for subjects during stimuli, includes subject 12 whose pain score did not change from 
moderate to severe. 
6.2 Repeated Measures ANOVA’s 
For a repeated measures ANOVA to be successful, an important assumption 
must be made: the relationship between pairs of experimental conditions is similar 
meaning that it is assumed that the variances are roughly equal. If the condition of 
sphericity is violated, then the effect is a loss of power (an increased probability of a 
Type II error) and a test statistic (F-statisic) that cannot be compared to the tabulated 
values of the F-distrubiton. However, there are corrections that can be made to the data 
including the Greenhouse-Gessier and the Hyunh-Feldt correction to adjust the degrees 
of freedom which makes the F-statistic more conservative. The Greenhouse-Geisser 
correction should be applied when ε <0.75 and the Hyunh-Feldt correction should be 




differences, between the variances of the variables, LF and HF; therefore, the condition 
for sphericity is not met (χ2 (5) = 31.744, p = 0.000). Since, ε <0.75, the Greenhouse-
Geisser correction must be applied to adjust the degrees of freedom44. 
 
Several repeated measures ANOVA with the Bonferroni adjustment were 
completed in SPSS 24 to determine the differences between the following: 
 Heart Rate (HRT) pre, HRT 1, HRT 2, HRT 3 
 LF pre, LF Norm 1, LF Norm 3, and LF Norm 3  
 HF pre, HF Norm 1, HF Norm 2, and HF Norm 3  
 VLF pre, VLF 1, VLF 2, VLF3  
 TP pre, TP 1, TP 2, TP 3 
 RMSSD pre, RMSDD 1, RMSSD 2, RMSSD 3 
 SDNN pre, SDNN 1, SDNN 2, SDNN 3 
 LF/HF pre, LF/HF 1, LF/HF 2, LF/HF  
 SC pre, SC post 1, SC post 2, SC post 3 
6.2.1 Heart Rate Variability  
The mean value for each group (i.e. pre-stimuli, post-stimuli 1, post-stimuli 2, 
post-stimuli 3) for all subjects and all variables (i.e. HRT, HF Norm, LF Norm, LF/HF, 
Total Power, VLF, SDNN, RMSSD, SDNN/RMSSD) were calculated in Microsoft 
Excel®. Repeated measures ANOVA were completed in SPSS for all variable groups. 
Table 9 shows these results for all subjects. Heart Rate is in beats per minutes, RMSSD 
and SDNN are in milliseconds, Total Power and Very Low Frequency (VLF) are in 
ms*2/Hz, HF norm and LF norm are both in normalized units, whereas LF/HF and 







Table 9. Multivariate tests of resting (pre) and post measures (post 1, post 2, post 3) with means 
(sd) for HRV. Repeated measures ANOVA show F-values, P-values, effect size (n2) for interaction 
effects, and observed power. 
Measure  Pre Post 1  Post 2 Post 3  ANOVA (group x time) 
F p 𝒏𝟐 Power 
HRT (bpm) 74.5 (14.9) 76.8 (14.3) 75.8 (13.9) 75.6 (13.3) 6.857 0.005 0.595 0.925 
LF Norm (n.u.) 53.4 (19.6) 60.0 (14.2) 64.4 (12.6) 62.2 (11.6) 5.401 0.011 0.536 0.847 
HF Norm (n.u.) 46.6 (19.6) 40.2 (14.0) 35.3 (12.9) 37.8 (11.6) 4.241 0.010 0.210 0.602 
LF/HF 1.7 (1.5) 1.9 (1.5) 2.3 (1.5) 2.0 (1.2) 5.769 0.009 0.553 0.871 



















2.611 0.093 0.359 0.514 
RMSSD (ms)  62.3 (28.8) 67.26 (40.3) 72.8 (51.9) 73.5 (61.4) 3.337 0.050 0.417 0.628 









1.895 0.177 0.289 0.386 
 
However, only the HRV variables relevant to the cross-correlation were further 
tested with more repeated measures ANOVA’s to determine sphericity, the differences 
between-subjects and within-subjects for pre, post 1, post 2, post 3 In addition, if 
statistical significance was found, then post-hoc tests with Bonferroni corrections were 
completed.  
Table 10 contains the results for Maulchy’s test of sphericity for LF Norm and HF 
Norm. Maulchy’s test of sphericity for LF and HF revealed that there are significant 
differences between the variances of the variables; therefore, the condition for sphericity 
is not met for LF (χ2 (5) = 31.744, p = 0.000) and HF (χ2 (5) = 33.331, p = 0.000). Since, 
ε <0.75 for both, the Greenhouse-Geisser correction must be applied to adjust the 
degrees of freedom. 
Table 10. Mauchly’sa Test of Sphericity 
Within 
Subjects 










Time LF .116 31.744 5 .000 .496 .535 .333 
HF .104 33.331 5 .000 .491 .528 .333 
Tests the null hypothesis that the error covariance matrix of the orthonormalized transformed dependent 




a. Design: Intercept  
 Within Subjects Design: Time 
b. May be used to adjust the degrees of freedom for the averaged tests of significance. Corrected tests are 
displayed in the Tests of Within-Subjects Effects table 
 
Table 11 shows the results of the repeated measures ANOVA for within-subjects 
effects for both LF and HF. Since the results were statistically significant for LF and HF 
(p< 0.05), post-hoc tests with Bonferroni corrections were done for the pairwise 
comparisons which is shown on Table 12.  

























1157.786 1.487 778.692 4.107 .040 .204 6.106 .590 
Greenhouse
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Difference (I-J) Std. Error Sig.b 
95% Confidence Interval for 
Differenceb 
Lower Bound Upper Bound 
LF 1 2 -6.621 4.371 .896 -19.771 6.528 
3 -11.039 4.285 .122 -23.931 1.853 
4 -8.800 4.364 .365 -21.929 4.329 
2 1 6.621 4.371 .896 -6.528 19.771 
3 -4.418* 1.446 .045 -8.767 -.069 
4 -2.178 2.338 1.000 -9.213 4.856 
3 1 11.039 4.285 .122 -1.853 23.931 
2 4.418* 1.446 .045 .069 8.767 
4 2.239 1.504 .937 -2.287 6.765 
4 1 8.800 4.364 .365 -4.329 21.929 
2 2.178 2.338 1.000 -4.856 9.213 
3 -2.239 1.504 .937 -6.765 2.287 
HF 1 2 6.418 4.263 .910 -6.406 19.241 
3 11.303 4.422 .127 -2.000 24.606 
4 8.800 4.364 .365 -4.329 21.929 
2 1 -6.418 4.263 .910 -19.241 6.406 
3 4.885* 1.432 .021 .578 9.193 
4 2.382 2.335 1.000 -4.643 9.408 
3 1 -11.303 4.422 .127 -24.606 2.000 
2 -4.885* 1.432 .021 -9.193 -.578 
4 -2.503 1.503 .692 -7.025 2.019 
4 1 -8.800 4.364 .365 -21.929 4.329 
2 -2.382 2.335 1.000 -9.408 4.643 
3 2.503 1.503 .692 -2.019 7.025 
Based on estimated marginal means 
*. The mean difference is significant at the .05 level. 
b. Adjustment for multiple comparisons: Bonferroni. 
 
Table 13 contains the results for Maulchy’s test of sphericity for the ratio of LF 
Norm and HF Norm. Maulchy’s test of sphericity revealed that there are significant 




is not met (χ2 (5) = 32.766, p = 0.000). Since, ε <0.75, the Greenhouse-Geisser 
correction must be applied to adjust the degrees of freedom. 
 
Table 13. Maulchy’s a Test of Sphericity for LF Norm/HF Norm 
Measure:   LF Norm /HF Norm 
Within 
Subjects 
Effect Mauchly's W 
Approx. Chi-
Square df Sig. 
Epsilonb 
Greenhouse-
Geisser Huynh-Feldt Lower-bound 
Time .108 32.766 5 .000 .543 .596 .333 
Tests the null hypothesis that the error covariance matrix of the orthonormalized transformed dependent 
variables is proportional to an identity matrix. 
a. Design: Intercept  
 Within Subjects Design: Time 
b. May be used to adjust the degrees of freedom for the averaged tests of significance. Corrected tests are 
displayed in the Tests of Within-Subjects Effects table. 
 
Table 14 shows the results of the repeated measures ANOVA for within-subjects 
effects for the ratio of LF Norm and HF Norm. Since the results were not statistically 
significant for LF Norm/HF Norm (p≠< 0.05), post-hoc tests with Bonferroni corrections 
were not done.   
Table 14. Tests of within subjects Effects for LF Norm/HF Norm 



























41.067 26.062 1.576 
     
 
6.2.2 Skin Conductance  
The mean value for each SC group (i.e. pre-stimuli, post-stimuli 1, post-stimuli 2, 




ANOVA were applied to these values to test the differences between them over time. 
Table 15 contains these results.  
Table 15. Multivariate tests of resting (pre) and post measures (post 1, post 2, post 3) with means 
(sd) for skin conductance. Repeated measures ANOVA show F-values, P-values, effect size (n2) for 
interaction effects, and observed power. 
Measure  Pre Post 1  Post 2 Post 3  ANOVA (group x time) 
F p 𝒏𝟐 Power 
SC (uS) 1.43 (1.60) 3.64 (2.97) 3.69 (3.17) 3.60 (3.27) 10.2 0.001 0.685 0.988 
 
Table 16 shows the Maulchy’s test of sphericity results for skin conductance. 
Maulchy’s test of sphericity revealed that there are significant differences between the 
variances of the variables; therefore, the condition for sphericity is not met (χ2 (5) = 
74.994, p = 0.000). Since, ε <0.75, the Greenhouse-Geisser correction must be applied 
to adjust the degrees of freedom. 
Table 16. Maulchy’s a Test of Sphericity for Skin Conductance 
Measure:   SC   
Within 
Subjects 
Effect Mauchly's W 
Approx. Chi-
Square df Sig. 
Epsilonb 
Greenhouse-
Geisser Huynh-Feldt Lower-bound 
time .006 74.994 5 .000 .390 .402 .333 
Tests the null hypothesis that the error covariance matrix of the orthonormalized transformed dependent 
variables is proportional to an identity matrix. 
a. Design: Intercept  
 Within Subjects Design: time 
b. May be used to adjust the degrees of freedom for the averaged tests of significance. Corrected tests are 
displayed in the Tests of Within-Subjects Effects table. 
 
Table 17 shows the results of the repeated measures ANOVA for between-
subjects effects for skin conductance. Since the results were not statistically significant 
for SC (p< 0.05), post-hoc tests with Bonferroni corrections were done which is shown 






Table 17. Tests of between-subject effects for skin conductance 
Measure:   SC   











Intercept 649.469 1 649.469 22.082 .000 .580 22.082 .993 
Error 470.577 16 29.411      
a. Computed using alpha = .05 
 
Table 18. Pairwise Comparisons for Skin Conductance 
Measure:   SC   
(I) time (J) time 
Mean 
Difference (I-J) Std. Error Sig.b 
95% Confidence Interval for 
Differenceb 
Lower Bound Upper Bound 
1 2 -2.217* .394 .000 -3.404 -1.031 
3 -2.263* .444 .001 -3.600 -.926 
4 -2.178* .472 .002 -3.597 -.760 
2 1 2.217* .394 .000 1.031 3.404 
3 -.045 .106 1.000 -.365 .274 
4 .039 .174 1.000 -.485 .563 
3 1 2.263* .444 .001 .926 3.600 
2 .045 .106 1.000 -.274 .365 
4 .084 .079 1.000 -.152 .321 
4 1 2.178* .472 .002 .760 3.597 
2 -.039 .174 1.000 -.563 .485 
3 -.084 .079 1.000 -.321 .152 
Based on estimated marginal means 
*. The mean difference is significant at the .05 level. 
b. Adjustment for multiple comparisons: Bonferroni. 
 
6.3 Cross-Correlation Coefficient Results 
The cross-correlation coefficient found by determining the peaks of the cross-
correlation plots between HF Norm and Phasic, LF Norm and Tonic were graphed in 




19 shows the descriptive statistics that were calculated for each. Figure 18 shows the 
correlation coefficient (r) between HF Norm and Phasic. Figure 19 shows the time delay 
between Norm and Phasic. Figure 20 shows the correlation coefficient (r) between LF 
Norm and Tonic. Figure 21 shows the time delay between LF Norm and Tonic. 
 
Table 19. Descriptive statistics for the cross-correlation coefficients 
Group  Mean  Median S.E. (𝝈𝟐) Max. Min. 95% CI IQR 




3.03 3.46 52.20 -16.60 (-4.03, 10.65) 8.95 
HF Norm 1 
and Phasic  
11.58 
(17.3) 
4.21 17.35 45.38 -17.06 (2.66, 20.50) 25.66 




35.16 10.63 98.07 -73.83 (5.95, 51.00) 48.66 
HF Norm 3 
and Phasic  
20.27 
(15.24) 
23.50 3.70 56.94 61.24 (12.43, 28.11) 22.24 





2.00 2.08 37.00 0.00 (0.5921, 9.41) 5.00 
TD HF Norm 1 
and Phasic  
33.82 
(28.61) 
27.00 6.94 109.00 0.00 (19.11, 48.53) 14.00 
TD HF Norm 2 
and Phasic  
64.65 
(38.45) 
53.00 9.33 130.00 7.00 (44.88, 84.42) 69.50 






9.18 130.00 1 (33.18, 72.11) 49.00 
LF Norm Pre 
and Tonic  
2.28 
(8.32) 
0.1 2.02 26.60 -6.40 (-2.00, 6.56) 6.95 
LF Norm 1 
and Tonic  
16.54 
(15.12) 
17.98 3.66 42.78 -14.77 (8.76, 24.31) 57.55 




16.77 2.96 45.70 3.68 (13.20, 25.74) 17.49 




17.50 3.28 42.00 -5.43 (12.38, 26.29) 21.74 
TD LF Norm 
Pre and Tonic 
7.12 
(10.31) 
3.00 2.50 34 33 (1.82, 12.42) 4.50 




30.00 6.41 94 0.00 (18.89, 46.05) 38 




33.00 8.90 131 0.00 (28.19, 65.92) 37.50 












Figure 16. Correlation Coefficient for HF Norm and Phasic 
 






Figure 18. Correlation Coefficient for LF Norm and Tonic 
 
 





Chapter 7: Discussion 
Analysis of Variance (ANOVA) (group x time) were done on the following 
measures: Heart Rate (HRT), LF Norm, HF Norm, LF/HF,TP, VLF, RMSSD, SDNN, and 
SDNN/RMSSD shown on Table 9 to determine if the application of the stimuli had an 
impact on these readings over time. Table 9 shows that heart rate increased on average 
when comparing pre-stimuli to post-stimuli measures. Such increase was statistically 
signficant (p=0.005) as shown in Table 9. It also shows that there was an increase on 
average in LF Norm values that was statistically significant (p=0.011), whereas the 
average HF Norm decreased which was also statistically signifcant (p=0.010). Since HF 
and LF are measures of parasympathetic and sympahtetic activity that work together to 
regulate the body, it is a good measure to look at the ratio of LF to HF which is shown 
on Table 9. On average, the LF/HF ratio increased as the stimuli were applied wich was 
statistically signficant (p=0.009). On average, VLF increased; however, it was not 
statistically signficant (p=0.093). Total Power (TP) increased on average but this was 
not statistically significant (p=0.617). Total Power is a sum of all activity a subject is 
experiencing (High Frequency + Low Frequency + Very Low Frequency). Root Mean 
Squared Standard Deviation (RMSSD) increased on average but this was not 
statistically significant (0.05), whereas SDNN also increased on average but it was 
statisticaly significant (p=0.030). Finally, the ratio of SDNN to RMSSD decreased; 
however, this was not statistically significant.  
Similarly, an ANOVA (group x time) was done on skin conductance to determine 
if the application of the stimuli had an impact on these readings over time. Table 15 
shows these results which determined that skin conductance increased as the stimuli 
were applied which was statistically signficant (p=0.001).  
Moreover, a repeated measures ANOVA with a Greenhouse-Geisser correction 
determined that mean the low frequency components of heart rate variability after the 
application of cold stimuli differed statistically siginificantly within-subjects (F(3, 1.487) = 
4.107, p = 0.040 < 0.05). Post hoc tests using the Bonferroni correction revealed that 




second stimuli (LF Norm post 2) (p = 0.045 <  0.05). Therefore, we can conclude that 
the application of cold stimuli elicits a statistically significant decrease in low frequency 
values of heart rate variability but only when comparing the first to the second stimuli. 
No other pairwise comparisons were statistically significant within-subjects. It also 
revealed that the application of cold stimuli was statistically significant for mean LF 
Norm between-subjects (F(1,6) = 377.227, p = 0.000 < 0.001).  
Similarly, another repeated measures ANOVA with a Greenhouse-Geisser 
correction determined that mean high frequency components of heart rate variability 
after the application of the cold stimuli differed statistically siginificantly within-
subjects(F(3, 1.473) = 4.241, p = 0.037 < 0.05). Post hoc tests using the Bonferroni 
correction revealed that only the first cold stimuli (HF Norm post 1) was statistically 
significantly different to the second cold stimuli (HF Norm post 2) (p = 0.021 < 0.05). 
Therefore, we can conclude that the application of cold stimuli elicits a statistically 
significant increase in low frequency values of heart rate variability but only when 
comparing the first to the second stimuli. No other pairwise comparisons were 
statistically significant within-subjects. It also revealed that the cold stimuli was 
statistically significant for mean HF Norm between-subjects (F(1,6)  = 167.177, p = 
0.000 < 0.001).  
To determine if there would be a statistically significant difference when cold 
stimuli were applied on the ratio between LF Norm and HF Norm, a repeated measures 
ANOVA with a Greenhouse-Geisser correction was applied. It determined that the 
application of cold stimulli was not statistically signifcant (F (3, 1.629) = 1.436, p = 
0.254) within-subjects. Therefore, we cannot conclude that the application of cold stimuli 
had an overall statistically significant difference on the ratio between low frequency and 
high frequency normalized components of heart rate variability. Since it was not 
statistically signficant, no post hoc tests were done.  
To determine if there would be a statistically significant difference when cold 
stimuli were applied on skin conductance, another repeated measures ANOVA with a 
Greenhouse-Geisser correction was applied. It determined that the application of cold 
stimuli was statistically signifcant within-subjects (F(3, 1.170) = 23.733, p = 0.000< 




stimuli were statistically significant between skin conductance between the following: 
SC pre and SC post 1 (p = 0.000< 0.05), SC pre and SC post 2 (p = 0.001< 0.05), and 
SC pre and SC post 3 (p = 0.002< 0.05). No other pairwise correlations were 
statistically significant.Therefore, it can be concluded that the application of cold stimuli 
elicits a statistically significant increase in skin conductance only from pre-stimuli to 
post-stimuli (1, 2, and 3) but not from stimuli to stimuli.  
Figure 16 shows the correlation coefficient (r) between HF Norm and Phasic. 
Table 19 contains the descriptive statistics for the high frequency components cross 
correlated with Phasic. HF pre and Phasic contains one outlier which is its minimum 
value (-16.60). It also contains one extreme outlier which is 52.20, a cross-correlation 
value found on subject 15. It is assumed that this extreme outlier exists for subject 15 
because the normalized cross-correlation result for its highest peak was higher than 
other subjects which can be attributed to subject variability. The subject may have been 
nervous before the application of the stimuli or may have already been stressed out by 
other factors not controlled in a lab setting. A low median value for HF Norm pre- is 
desirable because it can be confirmed that the subject was not experiencing significant 
stress and was in fact at rest before the stimuli were applied. Therefore, the application 
of a cold stimuli had an increasing effect on the cross-correlation between normalized 
high frequency heart rate variability values and phasic components of skin conductance.  
As shown on Figure 16, HF Norm 1 does not contain any outliers or extreme 
values, indicating that all subjects had a similar response to the first cold stimuli. An 
increase of 8.03 is shown (Figure 16) between median values of HF Norm pre- and HF 
Norm 1; however, it shows a larger spread described by a higher interquartile range. 
Since there is a clear increase between medians and quantiles, it can be concluded that 
the application of the first cold stimuli had an increasing effect on the normalized cross-
correlation between HF Norm and phasic values.  
HF Norm 2 contains one outlier (0.10) for subject 13. From the data, we can 
conclude that the correlation between HF Norm and phasic was not high for subject 13 
because the average difference between HF Norm 1 (62.7) and HF Norm 2 (61.8) was 
only 0.9. Such a small difference between the application of the first and second cold 




coefficient would be an outlier.  HF Norm 2 has a higher median than both HF Norm 1 
and HF Norm pre- but it has a much larger spread than both variables. 
 HF Norm 3 contains one outlier at 31.90 for subject 9 which is the same subject 
that had an outlier for HF pre. However, HF Norm 3 had a lower median than HF Norm 
2 but still higher than both HF Norm 1 and HF Norm pre. Such decrease could be 
attributed to the desensitization of subjects after two consecutive cold stimuli were 
applied. Subjects may have already become accustomed to the feeling which caused 
the 11.66 decrease between the two.  
Overall, Figure 16 and Table 19 show that the normalized correlation coefficient 
found for HF pre- has a lower median value (3.00) than all other variables HF1 (11.03), 
HF2 (35.16), and HF3 (23.50); however, HF 2 has the highest median but it has a 
greater spread. Therefore, it can be concluded that the strongest correlation between 
heart rate variability and skin conductance was found at HF2 which represents the 
normalized cross-correlation between HF and phasic values when the second cold 
stimuli were applied to subjects. Moreover, to determine if the normalized cross-
correlation between HF Norm and Phasic values were statistically significant, another 
repeated measures ANOVA with a Greenhouse-Geisser correction was applied to all 
values of the correlation (HF Norm 1 and Phasic 1, HF Norm 2 and Phasic 2, and HF 
Norm 3 and Phasic 3). It determined that the cross-correlation between HF Norm and 
Phasic was not statistically signifcant within-subjects (F(3, 1.628) = 3.079, p = 0.072). 
Since it was not statistically significant, post hoc tests were not applied. However, it 
revealed that the normalized cross-correlation between HF Norm and Phasic was 
statistically significant between-subjects (F(1,16) = 24.564, p = 0.000 < 0.05).  
Figure 17 shows the time delay between HF Norm and Phasic and Table 19 
shows the descriptive statistics. TD HF Norm pre- contains one extreme outlier at a 
value of 37 for subject 9. TD HF Norm pre- has a lower median value (2.00) than the 
rest of the variables: TD HF Norm 1 (27), TD HF Norm 2 (53), and TD HF Norm 3 (48). 
A low median value for TD HF Norm pre- is desirable because it can be confirmed that 
the subject was not experiencing significant stress and was in fact at rest before the 
stimuli were applied. Since the median TD HF Norm pre- value is lower than all 




effect on the time delay between the normalized high frequency values and phasic skin 
conductance components. TD HF Norm pre- has a small spread with an interquartile 
range of 5 which means that all subjects (except the extreme outlier) were at a similar 
relaxed state before the application of the cold stimuli. 
TD HF Norm 1 contains three extreme outliers which were 74 s (subject 16), 83 s 
(subject 9), and 109 s (subject 6). It also has one outlier at a value of 16 for subject 17. 
It is unclear why the time delay between the high frequency signal and phasic skin 
conductance signal was extremely high for these subjects since the mean value was 
33.82 s. TD HF Norm 1 had a larger spread than HF pre but the difference between 
their interquartile ranges was only 9; however, there was a 25 second increase in the 
time delay between the high frequency values and phasic signal before the stimuli and 
after the application of the first cold stimuli as seen on Figure 16.  
TD HF Norm 2 contains no outliers but has a very large spread among all 
subjects represented by the interquartile range of 69.50. Such variation may be 
attributed to the differences in gender and race between these subjects. However, TD 
HF2 contains the largest median, 25th and 75th percentiles which is consistent with the 
findings of the normalized cross-correlation result seen on Figure 16. Therefore, it can 
be concluded that the group with the highest correlation (HF 2) also had the largest time 
delay in seconds than any of the other groups. Thus, the greater the correlation 
between high frequency heart rate variability and phasic components of skin 
conductance, the higher the time delay between these two signals.   
TD HF Norm 3 contains two outliers with values 118 s (subject 6) and 130 s 
(subject 11). TD HF Norm 3 (48) had a lower median value than TD HF Norm 2 (53). 
Such 5 second decrease could be attributed to the desensitization of subjects after two 
consecutive cold stimuli were applied which is consistent with the results from the 
normalized cross-correlation between HF and phasic values as shown on Figure 16.  
Overall, Figure 17 shows that there is an increase in the time delay between the 
high frequency heart rate variability and the phasic components of skin conductance 
when cold stimuli were applied to the subjects. To determine if the time delay between 
HF Norm and Phasic were statistically significant when the normalized cross-correlation 




correction was applied to all values of TDHF (TDHF Norm 1, TDHF Norm 2, and TDHF 
Norm 3). It determined that the time delay between TDHF Norm and TD Phasic was 
statistically signifcant within-subjects (F(3, 1.776) = 13.741, p = 0.000<0.05). Post hoc 
tests with the Bonferroni correction were applied to the pairwise comparisons which 
revealed that the differences between TDHF Pre and TDHF 1 (p=0.001), TDHF Pre and 
TDHF 2 (p=0.000), TDHF Pre and TD HF 3 (p = 0.001) were all statistically significant. 
However, it revealed that there was no statistical significance between TDHF 1 and 
TDHF 2, TDHF 1 and TDHF 3, and TDHF 2 and TDHF 3. Nonetheless, it revealed that 
the normalized cross-correlatin between TDHF Norm and TD Phasic was statistically 
significant between-subjects (F(1,16) = 79.944, p = 0.000 < 0.05).  
Figure 18 shows the correlation coefficient (r) between LF Norm and Tonic and 
Table 19 shows the descriptive statistics. LF Norm Pre- has one extreme outlier at a 
value of 26.6 (subject 15), and another outlier at a value of 16.8 (subject 9). These 
outliers may have been caused by the anticipation of the stimuli for these subjects as 
these subjects also contain outliers on the correlation between high frequency values 
and phasic (Figure 18). However, LF Norm Pre- has a very small median (0.1) and a 
small spread with an interquartile range of 6.95. These low values are desirable for LF 
Norm Pre- because it means that on average all subjects (except subjects 15 and 19) 
were at a similar relaxed state before the application of the cold stimuli.  
LF Norm 1 has a higher median (17.96) than LF Norm pre (0.1) which means 
that the application of the first cold stimuli had a 17.86 increasing effect on the 
normalized cross-correlation between the low frequency signal of heart rate variability 
and the low frequency components of skin conductance. However, the spread of LF 
Norm 1 was much larger than the spread for LF Norm Pre- among all subjects with a 
difference of 50.6. Such variation may be attributed to the differences in gender and 
race between these subjects. Nonetheless, LF Norm 1 has a much larger median, 
mean, and 25th and 75th percentiles than LF Norm Pre- as shown in Figure 18 
Although the median of LF Norm 2 is higher than for LF Norm Pre- by 16.67, it is 
smaller than the median value for LF Norm 1. Since there is only a 1.21 decrease 
between the first cold stimulus and the second cold stimulus, then it is not clear if the 




two variables as this decrease was not statistically significant according to the repeated 
measures ANOVA with a Greenhouse-Geisser Correction.  
Although the median of LF Norm 3 is higher than for LF Norm Pre- by 17.4, it is 
smaller than the median for LF Norm 1 (17.98) and higher than the median of LF Norm 
2 (16.77). There is only a 0.73 increase between LF 2 Norm and LF Norm 3 that is not 
statistically significant according to a repeated measures ANOVA with a Greenhouse-
Geisser correction.  
Even though there is a difference between the median of all three, a repeated 
measures ANOVA with a Greenhouse-Geisser correction revealed that the pairwise 
comparisons between LF Norm 1, LF Norm 2, and LF Norm 3 were not statistically 
significant.  However, the repeated measures ANOVA revealed that there was a 
statistically significant difference (p<0.005) for the pairwise comparisons between LF 
Norm Pre- and LF Norm 1, LF Norm Pre- and LF Norm 2, and LF Norm Pre and LF 
Norm 3. Therefore, it can be concluded that there is a statistically significant difference 
between the normalized cross-correlation of low frequency heart rate variability and 
components and phasic skin conductance components between rest and the application 
of any of the three cold stimuli. However, on average the normalized cross-correlation of 
low frequency HRV and tonic SC were lower than the cross-correlation of high 
frequency HRV and phasic SC. Such result was hypothesized as it was believed that 
the application of stimuli would increase the sympathetic nervous system response 
which in turn would increase the high frequency components of heart rate variability as 
well as increase the phasic response of skin conductance.  
 Figure 19 shows the time delay (TD) between LF Norm and Tonic. TDLF Norm 
Pre- as two extreme outliers (subjects 16 and 11) at a value of 34 s. TDLF Norm Pre- 
has a very low median value (3s) and a small spread denoted by its interquartile range 
(4.50). These low values are desirable for TDLF Norm Pre- because it means that on 
average all subjects (except subjects 16 and 11) were at a similar relaxed state before 
the application of the cold stimuli. 
TDLF Norm 1 contains a higher median than TDLF Norm Pre- which means that 
there was an average increase in the time delay between the two signals when the first 




and Tonic contains a large spread among all subjects with denoted by its interquartile 
range of 38 which is an increase in variability of 33.50. TDLF Norm 1 contains no 
outliers.   
TDLF Norm 2 contains a higher median (33s) than TDLF Norm 1 and TDLF 
Norm Pre; however, the difference was only an average of 3 seconds among subjects. 
The spread for TDLF Norm 2 was smaller by 4 seconds. TDLF Norm 2 contains two 
outliers and one extreme outliers with values 102 (subject 2), 112 (subject 10), and 131 
(subject 5), respectively.    
TDLF Norm 3 contains a higher median (55s) than TDLF Norm 2, TDLF Norm 1, 
and TDLF Norm Pre. There was a larger increase of (22 seconds) in the median 
between TDLF Norm 3 and TDLF Norm 2. However, the spread of TDLF Norm 3 was 
almost double than TDLF Norm 2. TDLF Norm 3 contains no outliers.  To determine if 
the time delay between LF Norm and Tonic signals were statistically significant (when 
the normalized cross-correlation was applied), another repeated measures ANOVA with 
a Greenhouse-Geisser correction was applied to all values of TDLF (TDLF Norm 1, 
TDLF Norm 2, and TDLF Norm 3). It determined that the time delay between TDLF 
Norm and TD Tonic was statistically signifcant within-subjects (F(3, 2.513) = 12.379, p = 
0.000<0.05). Post hoc tests with the Bonferroni correction were applied to the pairwise 
comparisons which revealed that the differences between TDLF Pre and TDLF 1 
(p=0.000), TDLF Pre and TDLF 2 (p=0.004), TDLF Pre and TD LF 3 (p = 0.001), and 
TDLF 2 and TDLF 3 (p=0.034) were all statistically significant. However, it revealed that 
there was no statistical significance between TDLF 1 and TDLF 2, and TDLF 2 and 
TDLF 3. Nonetheless, it revealed that the normalized cross-correlation between TDLF 
Norm and TD Tonic was statistically significant between-subjects (F(1,16) = 59.193, p = 




Chapter 8: Conclusions 
Currently, heart rate variability and skin conductance are used as two different 
measures of sympathetic activity. While we cannot measure pain directly, we can use 
skin conductance and heart rate variability as an indirect measure of pain. Therefore, 
this study serves as a pilot study in which future applications include improving the 
accuracy of pain reporting by utilizing two measures of sympathetic activity instead of 
just one by identifying the cross-correlation between these signals. Heart rate variability 
and skin conductance were evaluated in this work, specifically, the high and low 
frequency components of the power spectrum of HRV and the phasic and tonic 
components of skin conductance. HRV Live! is a software used to measure heart rate 
variability using a PPG sensor that contains the capabilities via algorithms to obtain 
HRT, SDNN, RMSSD, LF, HF, VLF, and TP for each subject. Consensys is another 
software used to measure skin conductance via a GSR. LEDALAB, a MATLAB-based 
software was used to separate the tonic and phasic components of skin conductance. 
A data processing code was developed in MATLAB to perform the normalized cross-
correlation between HF and phasic and LF and tonic.  
The findings of this study show that on average heart rate and low frequency 
increased as the stimuli got colder, whereas high frequency decreased. Skin 
conductance activity also increased with application of cold stimuli.  An increase in heart 
rate and skin conductance during pain confirms previous literature that have observed 
this relationship with either variable or both on a wide range of pain studies including 
cold pain45,46,47 electric shock48,49, evoked back pain50, evoked muscle pain51, evoked 
esophageal pain52, and post-operative pain53. Other studies have also observed greater 
low frequency values with lower temperatures at which subjects first identified pain10.  
In this study, it was found that on average there is a strong cross-correlation 
between HRV and SC only when stimuli is applied, when no stimuli is applied the cross-
correlation is small. For high frequency and phasic, HF Norm 2 and Phasic have the 
highest cross-correlation (35.16) and time delay (53 s). It is believed that the higher 
correlation for the second cold stimuli is because by the third stimuli, the subjects were 




this case, high frequency heart rate variability responded first rather than phasic skin 
conductance level. LF 1 and Tonic have the highest cross correlation coefficient but LF 
2 and Tonic has the highest time delay (55 s) for its group. Overall, the low frequency 
normalized cross-correlation with tonic were lower than the high frequency normalized 
cross-correlation with phasic which is expected as tonic skin conductance components 
do not reflect stimuli spikes, rather the signal is just a background steady signal.  
Future work would require performing a linear mixed model to determine if there 
is a correlation between heart rate variability and skin conductance to numerical pain 
levels. This study should be done on a larger scale with healthy populations that include 
those older than college age and with a more even number of males and females. If 
those results yield statistical significance, another study should be conducted with 
populations suffering from chronic pain to determine if this model could be used to 
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Please indicate your level of pain corresponding to the applied stimulus, using 
the scale below. 
 







 – MATLAB Scripts 
The scripts developed in MATLAB to find the normalized cross-correlation 
between heart rate variability and skin conductance will be attached in this section. The 
first script used to export the raw skin conductance signal into MATLAB is labeled as 
“Skin Conductance 1”. This script calls for another script labeled as “Kim” that creates a 
.mat file that contains the raw skin conductance values to be imported into LEDALAB. 
At this point, LEDALAB has to be run and the .mat file is imported as well as the plain 
text event file. Another script used to get the data from LEDALAB is labeled as “Get 
Data” and this file plots the phasic and tonic components of skin conductance. Finally, a 
script labeled as “Xcorr one by one” computes the normalized cross-correlation between 
HF and Phasic and LF and Tonic. The LEDALAB software and the xcorr function is a 
built in MATLAB function that can be found on the following links: 
LEDALAB: http://www.ledalab.de/  
Xcorr: https://www.mathworks.com/help/signal/ref/xcorr.html  
 
%Skin Conductance 1 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
% 
%The purpose of this code is to read all of the files raw Skin Conductance 
data  
%for all subjects (baseline and stimuli)only so that they may be 
%placed into LEDALAB for data processing, specifically separating out 
%the phasic and tonic components for SC. This code calls out "kim" a  
%separate code used to interface with LEDALAB. This code is meant to be 
%run in sections 
  
%% subject 1  




SC = xlsread(filename, 'E3:E320'); 
Time = xlsread(filename, 'C3:C320'); 
  
%read excel file for SC stimuli  
filename= 'C:\Users\cruzmolinag12\Documents\Skin 
Conductance_TimeFix\Study102617_Session1_Shimmer_3BD6_Calibrated_SD_subject1_
stimuli plus after'; 
SC = xlsread(filename, 'E3:E949'); 




 kim; %runs the script 'kim' that interfaces with ledalab 
%% subject 2 
 
%read excel file for SC baseline   
% filename= 'C:\Users\cruzmolinag12\Documents\Skin 
Conductance_TimeFix\Study102617_Session2_Shimmer_3BD6_Calibrated_PC_subject2_
baseline'; 
% SC = xlsread(filename, 'E3:E337'); 
% Time = xlsread(filename, 'C3:C337'); 
  




SC = xlsread(filename, 'E3:E429'); 
Time = xlsread(filename, 'C3:C429'); 
  
kim; %runs the script 'kim' that interfaces with ledalab 
  
%% subject 3 
%read excel file for SC baseline  
% filename= 'C:\Users\cruzmolinag12\Documents\Skin 
Conductance_TimeFix\Study102617_Session4_Shimmer_3BD6_Calibrated_PC_Subj3_bas
eline'; 
% SC = xlsread(filename, 'E3:E304'); 
% Time = xlsread(filename, 'C3:C304'); 
  




SC = xlsread(filename, 'E3:E554'); 
Time = xlsread(filename, 'C3:C554'); 
  
kim; %runs the script 'kim' that interfaces with ledalab 
%% subject 4 




SC = xlsread(filename, 'E3:E310'); 
Time = xlsread(filename, 'C3:C310'); 
  




SC = xlsread(filename, 'E3:E544'); 
Time = xlsread(filename, 'C3:C544'); 
  
kim; %runs the script 'kim' that interfaces with ledalab 
  
%% subject 5 







SC = xlsread(filename, 'E3:E305'); 
Time = xlsread(filename, 'C3:C305'); 
  
% %read excel file for SC stimuli  
% filename= 'C:\Users\cruzmolinag12\Documents\Skin 
Conductance_TimeFix\Study102617_Session10_Shimmer_3BD6_Calibrated_PC_subj5_st
imuli'; 
% SC = xlsread(filename, 'E3:E557'); 
% Time = xlsread(filename, 'C3:C557'); 
  
kim; %runs the script 'kim' that interfaces with ledalab 
%% subject 6 
  




SC = xlsread(filename, 'E3:E308'); 
Time = xlsread(filename, 'C3:C308'); 
  
% %read excel file for SC stimuli  
% filename= 'C:\Users\cruzmolinag12\Documents\Skin 
Conductance_TimeFix\Study102617_Session13_Shimmer_3BD6_Calibrated_PC_Subj6_st
imuli'; 
% SC = xlsread(filename, 'E3:E609'); 
% Time = xlsread(filename, 'C3:C609'); 
  
kim; %runs the script 'kim' that interfaces with ledalab  
  
%% subject 7  




SC = xlsread(filename, 'E3:E303'); 
Time = xlsread(filename, 'C3:C303'); 
  
% %read excel file for SC stimuli  
% filename= 'C:\Users\cruzmolinag12\Documents\Skin 
Conductance_TimeFix\Study102617_Session15_Shimmer_3BD6_Calibrated_PC_subj7_st
imuli'; 
% SC = xlsread(filename, 'E3:E572'); 
% Time = xlsread(filename, 'C3:C572'); 
  
kim; %runs the script 'kim' that interfaces with ledalab  
%% Subject 8 
%do not have SC file due to an issue with the CONSENSYS program 
  
  
%% Subject 9 
  







SC = xlsread(filename, 'E3:E303'); 
Time = xlsread(filename, 'C3:C303'); 
  
%read excel file for SC stimuli  
% filename= 'C:\Users\cruzmolinag12\Documents\Skin 
Conductance_TimeFix\Study102617_Session20_Shimmer_3BD6_Calibrated_PC_subjt9_s
timuli'; 
% SC = xlsread(filename, 'E3:E438'); 
% Time = xlsread(filename, 'C3:C438'); 
  
kim; %runs the script 'kim' that interfaces with ledalab  
  
  
%% Subject 10 




SC = xlsread(filename, 'E3:E302'); 
Time = xlsread(filename, 'C3:C302'); 
  
%read excel file for SC stimuli  
% filename= 'C:\Users\cruzmolinag12\Documents\Skin 
Conductance_TimeFix\Study102617_Session22_Shimmer_3BD6_Calibrated_PC_subj10_s
timuli'; 
% SC = xlsread(filename, 'E3:E636'); 
% Time = xlsread(filename, 'C3:C636'); 
  
kim; %runs the script 'kim' that interfaces with ledalab  
%% Subject 11 




SC = xlsread(filename, 'E3:E310');  
Time = xlsread(filename, 'C3:C310');  
  
%read excel file for SC stimuli  
% filename= 'C:\Users\cruzmolinag12\Documents\Skin 
Conductance_TimeFix\Study11217_Session2_Shimmer_3BD6_Calibrated_PC_subj11_sti
muli'; 
% SC = xlsread(filename, 'E3:E663'); 
% Time = xlsread(filename, 'C3:C663'); 
  
kim; %runs the script 'kim' that interfaces with ledalab  





SC = xlsread(filename, 'E3:E308');  






% filename= 'C:\Users\cruzmolinag12\Documents\Skin 
Conductance_TimeFix\Study11217_Session4_Shimmer_3BD6_Calibrated_PC_subj12_sti
muli'; 
% SC = xlsread(filename, 'E3:E604');  










SC = xlsread(filename, 'E3:E326');  
Time = xlsread(filename, 'C3:C326');  
  
%SC stimuli 
% filename= 'C:\Users\cruzmolinag12\Documents\\Skin 
Conductance_TimeFix\Study11217_Session6_Shimmer_3BD6_Calibrated_PC_subj13_sti
muli'; 
% SC = xlsread(filename, 'E3:E426');  
% Time = xlsread(filename, 'C3:C426');  
  
kim; 






SC = xlsread(filename, 'E3:E308');  
Time = xlsread(filename, 'C3:C308');  
  
% %SC stimuli 
% filename= 'C:\Users\cruzmolinag12\Documents\\Skin 
Conductance_TimeFix\Study11217_Session8_Shimmer_3BD6_Calibrated_PC_subj14_sti
muli'; 
% SC = xlsread(filename, 'E3:E484');  








SC = xlsread(filename, 'E3:E307');  






% filename= 'C:\Users\cruzmolinag12\Documents\Skin 
Conductance_TimeFix\Study11217_Session10_Shimmer_3BD6_Calibrated_PC_subj15_st
imuli'; 
% SC = xlsread(filename, 'E3:E463');  
% Time = xlsread(filename, 'C3:C463');  
  
kim; 




SC = xlsread(filename, 'E3:E303');  
Time = xlsread(filename, 'C3:C303');  
  
%SC stimuli 
% filename= 'C:\Users\cruzmolinag12\Documents\Skin 
Conductance_TimeFix\Study11217_Session12_Shimmer_3BD6_Calibrated_PC_subj16_st
imuli'; 
% SC = xlsread(filename, 'E3:E542');  








SC = xlsread(filename, 'E3:E362');  
Time = xlsread(filename, 'C3:C362');  
  
%SC stimuli 
% filename= 'C:\Users\cruzmolinag12\Documents\Skin 
Conductance_TimeFix\Study11217_Session14_Shimmer_3BD6_Calibrated_PC_subj17_st
imuli'; 
% SC = xlsread(filename, 'E3:E484');  
% Time = xlsread(filename, 'C3:C484');  
  
kim; 






SC = xlsread(filename, 'E3:E312');  
Time = xlsread(filename, 'C3:C312');  
  
%SC stimuli 
% filename= 'C:\Users\cruzmolinag12\Documents\Skin 
Conductance_TimeFix\Study11217_Session16_Shimmer_3BD6_Calibrated_PC_subj18_st
imuli'; 
% SC = xlsread(filename, 'E3:E543');  











SC = xlsread(filename, 'E3:E302');  
Time = xlsread(filename, 'C3:C302');  
  
%SC stimuli 
% filename= 'C:\Users\cruzmolinag12\Documents\Skin 
Conductance_TimeFix\Study11217_Session18_Shimmer_3BD6_Calibrated_PC_subj19_st
imuli'; 
% SC = xlsread(filename, 'E3:E423');  






% The purpose of this script is to interface with LEDALAB and create an 
% arbitrary mat file for each subject 
data.conductance = SC; 
data.time        = 1:1:length(SC); 
data.timeoff     = 0; 
  
% Baseline 
data.event(1).time = []; 
data.event(1).nid  = []; 
data.event(1).name = []; 








%%The purpose of this code is to get the data from the LEDALAB interface 
%%after LEDALAB separated the tonic and phasic components of SC. This code  




handle = get(gcf); %get current figure 
handleSub=get(handle.Children(43)); %get the children from array position 43 
  
handleTonic = get(handleSub.Children(11)); %tonic data 
signalTonic = handleTonic.YData; 
  
handlePhasic = get(handleSub.Children(12)); %phasic data 







    subplot(1,2,1); plot(signalTonic,'k'); 
    title('Tonic data'); 
    subplot(1,2,2); plot(signalPhasic,'b');  
    title('Phasic data'); 
  
hold off;  
  
 
%Xcorr one by one 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%%% 
%%This code is used to preform the normalized cross-correlation on each 
individual 




%% subject 2 
filename = 'C:\Users\cruzmolinag12\Documents\HRV\subject 2'; 
  
%HRV LF and HF Values subject 2 
LF_Norm_B = xlsread(filename, 'N3:N7'); %LF norm for baseline 
LF_Norm_S1 = xlsread(filename, 'N8:N69'); %LF norm for stimuli 1 
LF_Norm_S2 = xlsread(filename,'N70:N115'); %LF norm for stimuli 2 
LF_Norm_S3 = xlsread(filename,'N116:N131'); %LF norm for stimuli 3 
  
HF_Norm_B = xlsread(filename, 'O3:O7'); %HF norm for baseline 
HF_Norm_S1 = xlsread(filename, 'O8:O69'); %HF norm for stimuli 1 
HF_Norm_S2 = xlsread(filename, 'O70:O115'); %HF norm for stimuli 2 
HF_Norm_S3 = xlsread(filename, 'O116:O131'); %HF norm for stimuli  
  
Time_B = xlsread(filename, 'C3:C7'); %Time for baseline  
Time_S = xlsread(filename, 'C8:C131'); %Time for stimuli 
  
























































































tonic = tonic(:)-mean(tonic(:)); 
phasic = phasic(:)-mean(phasic(:)); 
  
%pre 
tonic2 = tonic2(:)-mean(tonic2(:)); 






[C1,L1] = xcorr(LF_Norm_B/std(LF_Norm_B),tonic2/std(tonic2)); %xcorr of tonic 
and LF pre 
% plot(L1/fs,C1,'b'); 
% ylim([-80 80]); 




[C2,L2] = xcorr(LF_Norm_S1/std(LF_Norm_S1),tonic/std(tonic)); %xcorr of tonic 
and LF post 
plot(L2/fs,C2,'r',L1/fs,C1,'-.k'); 
legend('LF post 1 and Tonic', 'LF pre and Tonic'); 
ylim([-80 100]); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 




[C3,L3] = xcorr(LF_Norm_S2/std(LF_Norm_S2),tonic/std(tonic)); %xcorr of tonic 
and LF post 
plot(L3/fs,C3,'r',L1/fs,C1,'-.k'); 
legend('LF post 2 and Tonic', 'LF pre and Tonic'); 
ylim([-80 100]); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 
title('Subject 2: xcorr LF2 and Tonic'); 
  
subplot(1,3,3); 
[C4,L4] = xcorr(LF_Norm_S3/std(LF_Norm_S3),tonic/std(tonic)); %xcorr of tonic 
and LF post 
plot(L4/fs,C4, 'r',L1/fs,C1,'-.k'); 
legend('LF post 3 and Tonic', 'LF pre and Tonic'); 
ylim([-80 100]); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 
title('Subject 2: xcorr LF3 and Tonic'); 
  







[C5,L5] = xcorr(HF_Norm_B/std(HF_Norm_B),phasic2/std(phasic2));  
% plot(L5/fs,C5,'b'); 
% ylim([-80 80]); 




[C6,L6] = xcorr(HF_Norm_S1/std(HF_Norm_S1),phasic/std(phasic));  
plot(L6/fs,C6,'r', L5/fs,C5,'-.k'); 
ylim([-80 100]); 
legend('HF post 1 and Phasic', 'HF pre and Phasic'); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 




[C7,L7] = xcorr(HF_Norm_S2/std(HF_Norm_S2),phasic/std(phasic));  
plot(L7/fs,C7,'r',L5/fs,C5,'-.k'); 
ylim([-80 100]); 
legend('HF post 2 and Phasic', 'HF pre and Phasic'); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 




[C8,L8] = xcorr(HF_Norm_S3/std(HF_Norm_S3),phasic/std(phasic));  
plot(L8/fs,C8,'r',L5/fs,C5,'-.k'); 
ylim([-80 100]); 
legend('HF post 3 and Phasic', 'HF pre and Phasic'); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 
title('Subject 2: xcorr HF3 and Phasic'); 
hold off; 
  
%% subject 3 data 
filename = 'C:\Users\cruzmolinag12\Documents\HRV\subject 3'; 
  
%HRV subject 3 
Time_B = xlsread(filename, 'C3:C15'); %Time for baseline  
LF_Norm_B = xlsread(filename, 'N3:N15'); %LF norm for baseline 
LF_Norm_S1 = xlsread(filename, 'N16:N45');  
LF_Norm_S2 = xlsread(filename, 'N46:N151'); 
LF_Norm_S3 = xlsread(filename, 'N152:N266'); 
  
HF_Norm_B = xlsread(filename, 'O3:O15');  
HF_Norm_S1 = xlsread(filename, 'O16:O45'); 
HF_Norm_S2 = xlsread(filename, 'O46:O151'); 
HF_Norm_S3 = xlsread(filename, 'O152:O266'); 

































































tonic = tonic(:)-mean(tonic(:)); 
phasic = phasic(:)-mean(phasic(:)); 
  
%pre 
tonic2 = tonic2(:)-mean(tonic2(:)); 






[C1,L1] = xcorr(LF_Norm_B/std(LF_Norm_B),tonic2/std(tonic2)); %xcorr of tonic 
and LF pre 
% plot(L1/fs,C1,'b'); 
% ylim([-80 80]); 




[C2,L2] = xcorr(LF_Norm_S1/std(LF_Norm_S1),tonic/std(tonic)); %xcorr of tonic 
and LF post 
plot(L2/fs,C2,'r',L1/fs,C1,'-.k'); 
legend('LF post 1 and Tonic', 'LF pre and Tonic'); 
ylim([-80 100]); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 




[C3,L3] = xcorr(LF_Norm_S2/std(LF_Norm_S2),tonic/std(tonic)); %xcorr of tonic 
and LF post 
plot(L3/fs,C3,'r',L1/fs,C1,'-.k'); 
legend('LF post 2 and Tonic', 'LF pre and Tonic'); 
ylim([-80 100]); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 
title('Subject 3: xcorr LF2 and Tonic'); 
  
subplot(1,3,3); 
[C4,L4] = xcorr(LF_Norm_S3/std(LF_Norm_S3),tonic/std(tonic)); %xcorr of tonic 
and LF post 
plot(L4/fs,C4, 'r',L1/fs,C1,'-.k'); 
legend('LF post 3 and Tonic', 'LF pre and Tonic'); 
ylim([-80 100]); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 
title('Subject 3: xcorr LF3 and Tonic'); 
  









% ylim([-80 80]); 




[C6,L6] = xcorr(HF_Norm_S1/std(HF_Norm_S1),phasic/std(phasic));  
plot(L6/fs,C6,'r', L5/fs,C5,'-.k'); 
ylim([-80 100]); 
legend('HF post 1 and Phasic', 'HF pre and Phasic'); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 




[C7,L7] = xcorr(HF_Norm_S2/std(HF_Norm_S2),phasic/std(phasic));  
plot(L7/fs,C7,'r',L5/fs,C5,'-.k'); 
ylim([-80 100]); 
legend('HF post 2 and Phasic', 'HF pre and Phasic'); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 




[C8,L8] = xcorr(HF_Norm_S3/std(HF_Norm_S3),phasic/std(phasic));  
plot(L8/fs,C8,'r',L5/fs,C5,'-.k'); 
ylim([-80 100]); 
legend('HF post 3 and Phasic', 'HF pre and Phasic'); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 
title('Subject 3:  xcorr HF3 and Phasic'); 
hold off; 
  
%% subject 4 
  
filename = 'C:\Users\cruzmolinag12\Documents\HRV\subject 4'; 
  
%used to plot log(LF norm) at baseline and during stimuli for subject 4 
LF_Norm_B = xlsread(filename, 'N3:N8'); %LF norm for baseline 
HF_Norm_B = xlsread(filename, 'O3:O8'); %HF norm for baseline 
Time_B = xlsread(filename, 'C3:C8'); %Time for baseline  
LF_Norm_S1 = xlsread(filename, 'N9:N61');%LF norm for stimuli 
LF_Norm_S2 = xlsread(filename, 'N62:N126'); 
LF_Norm_S3 = xlsread(filename, 'N127:N217'); 
  
HF_Norm_S1 = xlsread(filename, 'O9:O61'); %HF norm for stimuli 
HF_Norm_S2 = xlsread(filename, 'O62:O126');  
HF_Norm_S3 = xlsread(filename, 'O127:O217');  






















































































tonic = tonic(:)-mean(tonic(:)); 
phasic = phasic(:)-mean(phasic(:)); 
  
%pre 
tonic2 = tonic2(:)-mean(tonic2(:)); 






[C1,L1] = xcorr(LF_Norm_B/std(LF_Norm_B),tonic2/std(tonic2)); %xcorr of tonic 
and LF pre 
%plot(L1/fs,C1,'b'); 
%ylim([-80 100]); 




[C2,L2] = xcorr(LF_Norm_S1/std(LF_Norm_S1),tonic/std(tonic)); %xcorr of tonic 
and LF post 
plot(L2/fs,C2,'r',L1/fs,C1,'-.k'); 
legend('LF post 1 and Tonic', 'LF pre and Tonic'); 
ylim([-80 100]); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 
title('Subject 4: xcorr LF1 and Tonic'); 
  
%LF post 2 
subplot(1,3,2); 
[C3,L3] = xcorr(LF_Norm_S2/std(LF_Norm_S2),tonic/std(tonic)); %xcorr of tonic 
and LF post 
plot(L3/fs,C3,'r',L1/fs,C1,'-.k'); 
legend('LF post 2 and Tonic', 'LF pre and Tonic'); 
ylim([-80 100]); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 





% LF post 3 
subplot(1,3,3); 
[C4,L4] = xcorr(LF_Norm_S3/std(LF_Norm_S3),tonic/std(tonic)); %xcorr of tonic 
and LF post 
plot(L4/fs,C4, 'r',L1/fs,C1,'-.k'); 
legend('LF post 3 and Tonic', 'LF pre and Tonic'); 
ylim([-80 100]); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 
title('Subject 4: xcorr LF3 and Tonic'); 
  
%HF and Phasic  
%pre 
figure(2); 




[C6,L6] = xcorr(HF_Norm_S1/std(HF_Norm_S1),phasic/std(phasic));  
plot(L6/fs,C6,'r', L5/fs,C5,'-.k'); 
ylim([-80 100]); 
legend('HF post 1 and Phasic', 'HF pre and Phasic'); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 




[C7,L7] = xcorr(HF_Norm_S2/std(HF_Norm_S2),phasic/std(phasic));  
plot(L7/fs,C7,'r',L5/fs,C5,'-.k'); 
ylim([-80 100]); 
legend('HF post 2 and Phasic', 'HF pre and Phasic'); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 




[C8,L8] = xcorr(HF_Norm_S3/std(HF_Norm_S3),phasic/std(phasic));  
plot(L8/fs,C8,'r',L5/fs,C5,'-.k'); 
ylim([-80 100]); 
legend('HF post 3 and Phasic', 'HF pre and Phasic'); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 
title('Subject 4: xcorr HF3 and phasic'); 
hold off; 
  
%% subject 5 
filename = 'C:\Users\cruzmolinag12\Documents\HRV\subject 5'; 
  
%used to plot log(LF norm) at baseline and during stimuli for subject 5 
LF_Norm_B = xlsread(filename, 'N3:N6'); %LF norm for baseline 
HF_Norm_B = xlsread(filename, 'O3:O6'); %HF norm for baseline 





LF_Norm_S1 = xlsread(filename, 'N7:N49'); %LF norm for stimuli 
LF_Norm_S2 = xlsread(filename, 'N50:N188'); 
LF_Norm_S3 = xlsread(filename, 'N189:N248'); 
  
HF_Norm_S1 = xlsread(filename, 'O7:O49'); %HF norm for stimuli 
HF_Norm_S2 = xlsread(filename, 'O50:O188'); 
HF_Norm_S3 = xlsread(filename, 'O189:O248'); 
Time_S = xlsread(filename, 'C7:C248'); %Time for stimuli 
  






























































tonic = tonic(:)-mean(tonic(:)); 
phasic = phasic(:)-mean(phasic(:)); 
  
%pre 
tonic2 = tonic2(:)-mean(tonic2(:)); 





[C1,L1] = xcorr(LF_Norm_B/std(LF_Norm_B),tonic2/std(tonic2)); %xcorr of tonic 
and LF pre 
% plot(L1/fs,C1,'b'); 
% ylim([-65 65]); 
% title('Subject 5: Cross-Correlation of LF(pre) and Tonic'); 





[C2,L2] = xcorr(LF_Norm_S1/std(LF_Norm_S1),tonic/std(tonic)); %xcorr of tonic 
and LF post 
plot(L2/fs,C2,'r',L1/fs,C1,'-.k'); 
legend('LF post 1 and Tonic', 'LF pre and Tonic'); 
ylim([-80 100]); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 




[C3,L3] = xcorr(LF_Norm_S2/std(LF_Norm_S2),tonic/std(tonic)); %xcorr of tonic 
and LF post 
plot(L3/fs,C3,'r',L1/fs,C1,'-.k'); 
legend('LF post 2 and Tonic', 'LF pre and Tonic'); 
ylim([-80 100]); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 






[C4,L4] = xcorr(LF_Norm_S3/std(LF_Norm_S3),tonic/std(tonic)); %xcorr of tonic 
and LF post 
plot(L4/fs,C4, 'r',L1/fs,C1,'-.k'); 
legend('LF post 3 and Tonic', 'LF pre and Tonic'); 
ylim([-80 100]); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 
title('Subject 5: xcorr LF3 and Tonic'); 
  




[C5,L5] = xcorr(HF_Norm_B/std(HF_Norm_B),phasic2/std(phasic2));  
% plot(L5/fs,C5,'b'); 
% ylim([-80 80]); 




[C6,L6] = xcorr(HF_Norm_S1/std(HF_Norm_S1),phasic/std(phasic));  
plot(L6/fs,C6,'r', L5/fs,C5,'-.k'); 
ylim([-80 100]); 
legend('HF post 1 and Phasic', 'HF pre and Phasic'); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 




[C7,L7] = xcorr(HF_Norm_S2/std(HF_Norm_S2),phasic/std(phasic));  
plot(L7/fs,C7,'r',L5/fs,C5,'-.k'); 
ylim([-80 100]); 
legend('HF post 2 and Phasic', 'HF pre and Phasic'); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 




[C8,L8] = xcorr(HF_Norm_S3/std(HF_Norm_S3),phasic/std(phasic));  
plot(L8/fs,C8,'r',L5/fs,C5,'-.k'); 
ylim([-80 100]); 
legend('HF post 3 and Phasic', 'HF pre and Phasic'); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 
title('Subject 5:  xcorr HF3 and Phasic'); 
hold off; 
  
%% subject 6 
  
filename = 'C:\Users\cruzmolinag12\Documents\HRV\subject 6'; 
  
%used to plot log(LF norm) at baseline and during stimuli for subject 5 




HF_Norm_B = xlsread(filename, 'O3:O8'); %HF norm for baseline 
Time_B = xlsread(filename, 'C3:C8'); %Time for baseline  
LF_Norm_S1 = xlsread(filename, 'N9:N86');  
LF_Norm_S2 = xlsread(filename, 'N87:N166'); 
LF_Norm_S3 = xlsread(filename, 'N167:N316'); 
  
HF_Norm_S1 = xlsread(filename, 'O9:O86'); %HF norm for stimuli 
HF_Norm_S2 = xlsread(filename, 'O87:O166'); 
HF_Norm_S3 = xlsread(filename, 'O167:O316'); 





















































































tonic = tonic(:)-mean(tonic(:)); 
phasic = phasic(:)-mean(phasic(:)); 
  
%pre 
tonic2 = tonic2(:)-mean(tonic2(:)); 





[C1,L1] = xcorr(LF_Norm_B/std(LF_Norm_B),tonic2/std(tonic2)); %xcorr of tonic 
and LF pre 
% plot(L1/fs,C1,'b'); 
% ylim([-65 65]); 





[C2,L2] = xcorr(LF_Norm_S1/std(LF_Norm_S1),tonic/std(tonic)); %xcorr of tonic 





legend('LF post 1 and Tonic', 'LF pre and Tonic'); 
ylim([-80 100]); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 




[C3,L3] = xcorr(LF_Norm_S2/std(LF_Norm_S2),tonic/std(tonic)); %xcorr of tonic 
and LF post 
plot(L3/fs,C3,'r',L1/fs,C1,'-.k'); 
legend('LF post 2 and Tonic', 'LF pre and Tonic'); 
ylim([-80 100]); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 
title('Subject 6: xcorr LF2 and Tonic'); 
  
subplot(1,3,3); 
[C4,L4] = xcorr(LF_Norm_S3/std(LF_Norm_S3),tonic/std(tonic)); %xcorr of tonic 
and LF post 
plot(L4/fs,C4, 'r',L1/fs,C1,'-.k'); 
legend('LF post 3 and Tonic', 'LF pre and Tonic'); 
ylim([-80 100]); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 
title('Subject 6: xcorr LF3 and Tonic'); 
  




[C5,L5] = xcorr(HF_Norm_B/std(HF_Norm_B),phasic2/std(phasic2));  
% plot(L5/fs,C5,'b'); 
% ylim([-80 80]); 




[C6,L6] = xcorr(HF_Norm_S1/std(HF_Norm_S1),phasic/std(phasic));  
plot(L6/fs,C6,'r', L5/fs,C5,'-.k'); 
ylim([-80 100]); 
legend('HF post 1 and Phasic', 'HF pre and Phasic'); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 




[C7,L7] = xcorr(HF_Norm_S2/std(HF_Norm_S2),phasic/std(phasic));  
plot(L7/fs,C7,'r',L5/fs,C5,'-.k'); 
ylim([-80 100]); 
legend('HF post 2 and Phasic', 'HF pre and Phasic'); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 







[C8,L8] = xcorr(HF_Norm_S3/std(HF_Norm_S3),phasic/std(phasic));  
plot(L8/fs,C8,'r',L5/fs,C5,'-.k'); 
ylim([-80 100]); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 
legend('HF post 3 and Phasic', 'HF pre and Phasic'); 
title('Subject 6:  xcorr HF3 and Phasic'); 
hold off; 
  
%% subject 7 
  
filename = 'C:\Users\cruzmolinag12\Documents\HRV\subject 7'; 
  
%used to plot log(LF norm) at baseline and during stimuli for subject 7 
LF_Norm_B = xlsread(filename, 'N3:N6'); %LF norm for baseline 
HF_Norm_B = xlsread(filename, 'O3:O6'); %HF norm for baseline 
Time_B = xlsread(filename, 'C3:C6'); %Time for baseline  
  
LF_Norm_S1 = xlsread(filename, 'N7:N105'); 
LF_Norm_S2 = xlsread(filename, 'N106:N189'); 
LF_Norm_S3 = xlsread(filename, 'N190:N277'); 
  
HF_Norm_S1 = xlsread(filename, 'O7:O105'); %HF norm for stimuli 
HF_Norm_S2 = xlsread(filename, 'O106:O189');  
HF_Norm_S3 = xlsread(filename, 'O190:O277');  
Time_S = xlsread(filename, 'C7:C277'); %Time for stimuli 
  






























































tonic = tonic(:)-mean(tonic(:)); 
phasic = phasic(:)-mean(phasic(:)); 
  
%pre 
tonic2 = tonic2(:)-mean(tonic2(:)); 





[C1,L1] = xcorr(LF_Norm_B/std(LF_Norm_B),tonic2/std(tonic2)); %xcorr of tonic 
and LF pre 
% plot(L1/fs,C1,'b'); 
% ylim([-65 65]); 





[C2,L2] = xcorr(LF_Norm_S1/std(LF_Norm_S1),tonic/std(tonic)); %xcorr of tonic 





legend('LF post 1 and Tonic', 'LF pre and Tonic'); 
ylim([-80 100]); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 




[C3,L3] = xcorr(LF_Norm_S2/std(LF_Norm_S2),tonic/std(tonic)); %xcorr of tonic 
and LF post 
plot(L3/fs,C3,'r',L1/fs,C1,'-.k'); 
legend('LF post 2 and Tonic', 'LF pre and Tonic'); 
ylim([-80 100]); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 
title('Subject 7: xcorr LF2 and Tonic'); 
  
subplot(1,3,3); 
[C4,L4] = xcorr(LF_Norm_S3/std(LF_Norm_S3),tonic/std(tonic)); %xcorr of tonic 
and LF post 
plot(L4/fs,C4, 'r',L1/fs,C1,'-.k'); 
legend('LF post 3 and Tonic', 'LF pre and Tonic'); 
ylim([-80 100]); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 
title('Subject 7: xcorr LF3 and Tonic'); 
  




[C5,L5] = xcorr(HF_Norm_B/std(HF_Norm_B),phasic2/std(phasic2));  
% plot(L5/fs,C5,'b'); 
% ylim([-80 80]); 




[C6,L6] = xcorr(HF_Norm_S1/std(HF_Norm_S1),phasic/std(phasic));  
plot(L6/fs,C6,'r', L5/fs,C5,'-.k'); 
ylim([-80 100]); 
legend('HF post 1 and Phasic', 'HF pre and Phasic'); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 




[C7,L7] = xcorr(HF_Norm_S2/std(HF_Norm_S2),phasic/std(phasic));  
plot(L7/fs,C7,'r',L5/fs,C5,'-.k'); 
ylim([-80 100]); 
legend('HF post 2 and Phasic', 'HF pre and Phasic'); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 







[C8,L8] = xcorr(HF_Norm_S3/std(HF_Norm_S3),phasic/std(phasic));  
plot(L8/fs,C8,'r',L5/fs,C5,'-.k'); 
ylim([-80 100]); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 
legend('HF post 3 and Phasic', 'HF pre and Phasic'); 
title('Subject 7:  xcorr HF3 and Phasic'); 
hold off; 
  
%% subject 9 
filename = 'C:\Users\cruzmolinag12\Documents\HRV\subject 9'; 
  
%used to plot log(LF norm) at baseline and during stimuli for subject 9 
LF_Norm_B = xlsread(filename, 'N3:N4'); %LF norm for baseline 
HF_Norm_B = xlsread(filename, 'O3:O4'); %HF norm for baseline 
Time_B = xlsread(filename, 'C3:C4'); %Time for baseline  
LF_Norm_S1 = xlsread(filename, 'N4:N39'); %LF norm for stimuli 
LF_Norm_S2 = xlsread(filename, 'N40:N76'); 
LF_Norm_S3 = xlsread(filename, 'N77:N136'); 
  
HF_Norm_S1 = xlsread(filename, 'O4:O39'); %HF norm for stimuli 
HF_Norm_S2 = xlsread(filename, 'O5:O76'); 
HF_Norm_S3 = xlsread(filename, 'O77:O136'); 
Time_S = xlsread(filename, 'C5:C136'); %Time for stimuli 
  
























































tonic = tonic(:)-mean(tonic(:)); 
phasic = phasic(:)-mean(phasic(:)); 
  
%pre 
tonic2 = tonic2(:)-mean(tonic2(:)); 





[C1,L1] = xcorr(LF_Norm_B/std(LF_Norm_B),tonic2/std(tonic2)); %xcorr of tonic 
and LF pre 
% plot(L1/fs,C1,'b'); 
% ylim([-65 65]); 





[C2,L2] = xcorr(LF_Norm_S1/std(LF_Norm_S1),tonic/std(tonic)); %xcorr of tonic 
and LF post 
plot(L2/fs,C2,'r',L1/fs,C1,'-.k'); 
legend('LF post 1 and Tonic', 'LF pre and Tonic'); 
ylim([-80 100]); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 







[C3,L3] = xcorr(LF_Norm_S2/std(LF_Norm_S2),tonic/std(tonic)); %xcorr of tonic 
and LF post 
plot(L3/fs,C3,'r',L1/fs,C1,'-.k'); 
legend('LF post 2 and Tonic', 'LF pre and Tonic'); 
ylim([-80 100]); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 
title('Subject 9: xcorr LF2 and Tonic'); 
  
subplot(1,3,3); 
[C4,L4] = xcorr(LF_Norm_S3/std(LF_Norm_S3),tonic/std(tonic)); %xcorr of tonic 
and LF post 
plot(L4/fs,C4, 'r',L1/fs,C1,'-.k'); 
legend('LF post 3 and Tonic', 'LF pre and Tonic'); 
ylim([-80 100]); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 
title('Subject 9: xcorr LF3 and Tonic'); 
  




[C5,L5] = xcorr(HF_Norm_B/std(HF_Norm_B),phasic2/std(phasic2));  
% plot(L5/fs,C5,'b'); 
% ylim([-80 80]); 




[C6,L6] = xcorr(HF_Norm_S1/std(HF_Norm_S1),phasic/std(phasic));  
plot(L6/fs,C6,'r', L5/fs,C5,'-.k'); 
ylim([-80 100]); 
legend('HF post 1 and Phasic', 'HF pre and Phasic'); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 




[C7,L7] = xcorr(HF_Norm_S2/std(HF_Norm_S2),phasic/std(phasic));  
plot(L7/fs,C7,'r',L5/fs,C5,'-.k'); 
ylim([-80 100]); 
legend('HF post 2 and Phasic', 'HF pre and Phasic'); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 




[C8,L8] = xcorr(HF_Norm_S3/std(HF_Norm_S3),phasic/std(phasic));  
plot(L8/fs,C8,'r',L5/fs,C5,'-.k'); 
ylim([-80 100]); 
legend('HF post 3 and Phasic', 'HF pre and Phasic'); 





title('Subject 9:  xcorr HF3 and Phasic'); 
hold off; 
  
%% subject 10 
  
filename = 'C:\Users\cruzmolinag12\Documents\HRV\subject 10'; 
  
%used to plot log(LF norm) at baseline and during stimuli for subject 10 
LF_Norm_B = xlsread(filename, 'N3:N6'); %LF norm for baseline 
HF_Norm_B = xlsread(filename, 'O3:O6'); %HF norm for baseline 
Time_B = xlsread(filename, 'C3:C6'); %Time for baseline  
  
LF_Norm_S1 = xlsread(filename, 'N7:N93'); %LF norm for stimuli 
LF_Norm_S2 = xlsread(filename, 'N94:N214'); 
LF_Norm_S3 = xlsread(filename, 'N215:N336'); 
  
HF_Norm_S = xlsread(filename, 'O7:O336'); %HF norm for stimuli 
































































tonic = tonic(:)-mean(tonic(:)); 
phasic = phasic(:)-mean(phasic(:)); 
  
%pre 
tonic2 = tonic2(:)-mean(tonic2(:)); 





[C1,L1] = xcorr(LF_Norm_B/std(LF_Norm_B),tonic2/std(tonic2)); %xcorr of tonic 
and LF pre 
% plot(L1/fs,C1,'b'); 
% ylim([-65 65]); 





[C2,L2] = xcorr(LF_Norm_S1/std(LF_Norm_S1),tonic/std(tonic)); %xcorr of tonic 
and LF post 
plot(L2/fs,C2,'r',L1/fs,C1,'-.k'); 
legend('LF post 1 and Tonic', 'LF pre and Tonic'); 
ylim([-80 100]); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 




[C3,L3] = xcorr(LF_Norm_S2/std(LF_Norm_S2),tonic/std(tonic)); %xcorr of tonic 






legend('LF post 2 and Tonic', 'LF pre and Tonic'); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 
title('Subject 10: xcorr LF2 and Tonic'); 
  
subplot(1,3,3); 
[C4,L4] = xcorr(LF_Norm_S3/std(LF_Norm_S3),tonic/std(tonic)); %xcorr of tonic 
and LF post 
plot(L4/fs,C4, 'r',L1/fs,C1,'-.k'); 
ylim([-80 100]); 
legend('LF post 3 and Tonic', 'LF pre and Tonic'); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 
title('Subject 10: xcorr LF3 and Tonic'); 
  




[C5,L5] = xcorr(HF_Norm_B/std(HF_Norm_B),phasic2/std(phasic2));  
% plot(L5/fs,C5,'b'); 
% ylim([-80 80]); 




[C6,L6] = xcorr(HF_Norm_S1/std(HF_Norm_S1),phasic/std(phasic));  
plot(L6/fs,C6,'r', L5/fs,C5,'-.k'); 
ylim([-80 100]); 
legend('HF post 1 and Phasic', 'HF pre and Phasic'); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 




[C7,L7] = xcorr(HF_Norm_S2/std(HF_Norm_S2),phasic/std(phasic));  
plot(L7/fs,C7,'r',L5/fs,C5,'-.k'); 
ylim([-80 100]); 
legend('HF post 2 and Phasic', 'HF pre and Phasic'); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 




[C8,L8] = xcorr(HF_Norm_S3/std(HF_Norm_S3),phasic/std(phasic));  
plot(L8/fs,C8,'r',L5/fs,C5,'-.k'); 
ylim([-80 100]); 
legend('HF post 3 and Phasic', 'HF pre and Phasic'); 
title('Subject 10:  xcorr HF3 and Phasic'); 







%% subject 11 
  
filename = 'C:\Users\cruzmolinag12\Documents\HRV\subject 11'; 
  
%used to plot log(LF norm) at baseline and during stimuli for subject 11 
LF_Norm_B = xlsread(filename, 'N3:N51'); %LF norm for baseline 
HF_Norm_B = xlsread(filename, 'O3:O51'); %HF norm for baseline 
Time_B = xlsread(filename, 'C3:C51'); %Time for baseline  
LF_Norm_S1 = xlsread(filename, 'N52:N200'); %LF norm for stimuli 
LF_Norm_S2 = xlsread(filename, 'N201:N319'); 
LF_Norm_S3 = xlsread(filename, 'N320:N408'); 
  
HF_Norm_S1 = xlsread(filename, 'O52:O200'); %HF norm for stimuli 
HF_Norm_S2 = xlsread(filename, 'O201:O319'); 
HF_Norm_S3 = xlsread(filename, 'O320:O408'); 























































































tonic = tonic(:)-mean(tonic(:)); 
phasic = phasic(:)-mean(phasic(:)); 
  
%pre 
tonic2 = tonic2(:)-mean(tonic2(:)); 








[C1,L1] = xcorr(LF_Norm_B/std(LF_Norm_B),tonic2/std(tonic2)); %xcorr of tonic 
and LF pre 
% plot(L1/fs,C1,'b'); 
% ylim([-65 65]); 





[C2,L2] = xcorr(LF_Norm_S1/std(LF_Norm_S1),tonic/std(tonic)); %xcorr of tonic 
and LF post 
plot(L2/fs,C2,'r',L1/fs,C1,'-.k'); 
legend('LF post 1 and Tonic', 'LF pre and Tonic'); 
ylim([-80 100]); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 




[C3,L3] = xcorr(LF_Norm_S2/std(LF_Norm_S2),tonic/std(tonic)); %xcorr of tonic 
and LF post 
plot(L3/fs,C3,'r',L1/fs,C1,'-.k'); 
ylim([-80 100]); 
legend('LF post 2 and Tonic', 'LF pre and Tonic'); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 
title('Subject 11: xcorr LF2 and Tonic'); 
  
subplot(1,3,3); 
[C4,L4] = xcorr(LF_Norm_S3/std(LF_Norm_S3),tonic/std(tonic)); %xcorr of tonic 
and LF post 
plot(L4/fs,C4, 'r',L1/fs,C1,'-.k'); 
ylim([-80 100]); 
legend('LF post 3 and Tonic', 'LF pre and Tonic'); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 
title('Subject 11: xcorr LF3 and Tonic'); 
  




[C5,L5] = xcorr(HF_Norm_B/std(HF_Norm_B),phasic2/std(phasic2));  
% plot(L5/fs,C5,'b'); 
% ylim([-80 80]); 




[C6,L6] = xcorr(HF_Norm_S1/std(HF_Norm_S1),phasic/std(phasic));  
plot(L6/fs,C6,'r', L5/fs,C5,'-.k'); 
ylim([-80 100]); 
legend('HF post 1 and Phasic', 'HF pre and Phasic'); 









[C7,L7] = xcorr(HF_Norm_S2/std(HF_Norm_S2),phasic/std(phasic));  
plot(L7/fs,C7,'r',L5/fs,C5,'-.k'); 
ylim([-80 100]); 
legend('HF post 2 and Phasic', 'HF pre and Phasic'); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 




[C8,L8] = xcorr(HF_Norm_S3/std(HF_Norm_S3),phasic/std(phasic));  
plot(L8/fs,C8,'r',L5/fs,C5,'-.k'); 
ylim([-80 100]); 
legend('HF post 3 and Phasic', 'HF pre and Phasic'); 
title('Subject 11:  xcorr HF3 and Phasic'); 




%% subject 12 
%investigate this one 
filename = 'C:\Users\cruzmolinag12\Documents\HRV\subject 12'; 
  
%used to plot log(LF norm) at baseline and during stimuli for subject 12 
LF_Norm_B = xlsread(filename, 'N3:N15'); %LF norm for baseline 
HF_Norm_B = xlsread(filename, 'O3:O15'); %HF norm for baseline 
Time_B = xlsread(filename, 'C3:C15'); %Time for baseline  
  
LF_Norm_S1 = xlsread(filename, 'N16:N79'); %LF norm for stimuli 
LF_Norm_S2 = xlsread(filename, 'N80:N161'); 
LF_Norm_S3 = xlsread(filename, 'N162:N321'); 
  
HF_Norm_S1 = xlsread(filename, 'O16:O79'); %HF norm for stimuli 
HF_Norm_S2 = xlsread(filename, 'O80:O161'); 
HF_Norm_S3 = xlsread(filename, 'O162:O321'); 
























































































tonic = tonic(:)-mean(tonic(:)); 
phasic = phasic(:)-mean(phasic(:)); 
  
%pre 
tonic2 = tonic2(:)-mean(tonic2(:)); 





[C1,L1] = xcorr(LF_Norm_B/std(LF_Norm_B),tonic2/std(tonic2)); %xcorr of tonic 
and LF pre 
% plot(L1/fs,C1,'b'); 
% ylim([-65 65]); 





[C2,L2] = xcorr(LF_Norm_S1/std(LF_Norm_S1),tonic/std(tonic)); %xcorr of tonic 
and LF post 
plot(L2/fs,C2,'r',L1/fs,C1,'-.k'); 
legend('LF post 1 and Tonic', 'LF pre and Tonic'); 
ylim([-80 100]); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 




[C3,L3] = xcorr(LF_Norm_S2/std(LF_Norm_S2),tonic/std(tonic)); %xcorr of tonic 
and LF post 
plot(L3/fs,C3,'r',L1/fs,C1,'-.k'); 
ylim([-80 100]); 
legend('LF post 2 and Tonic', 'LF pre and Tonic'); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 




[C4,L4] = xcorr(LF_Norm_S3/std(LF_Norm_S3),tonic/std(tonic)); %xcorr of tonic 






legend('LF post 3 and Tonic', 'LF pre and Tonic'); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 
title('Subject 12: xcorr LF3 and Tonic'); 
  




[C5,L5] = xcorr(HF_Norm_B/std(HF_Norm_B),phasic2/std(phasic2));  
% plot(L5/fs,C5,'b'); 
% ylim([-80 80]); 




[C6,L6] = xcorr(HF_Norm_S1/std(HF_Norm_S1),phasic/std(phasic));  
plot(L6/fs,C6,'r', L5/fs,C5,'-.k'); 
ylim([-80 100]); 
legend('HF post 1 and Phasic', 'HF pre and Phasic'); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 




[C7,L7] = xcorr(HF_Norm_S2/std(HF_Norm_S2),phasic/std(phasic));  
plot(L7/fs,C7,'r',L5/fs,C5,'-.k'); 
ylim([-80 100]); 
legend('HF post 2 and Phasic', 'HF pre and Phasic'); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 




[C8,L8] = xcorr(HF_Norm_S3/std(HF_Norm_S3),phasic/std(phasic));  
plot(L8/fs,C8,'r',L5/fs,C5,'-.k'); 
ylim([-80 100]); 
legend('HF post 3 and Phasic', 'HF pre and Phasic'); 
title('Subject 12:  xcorr HF3 and Phasic'); 




%% subject 13 
  
filename = 'C:\Users\cruzmolinag12\Documents\HRV\subject 13'; 
  
%used to plot log(LF norm) at baseline and during stimuli for subject 13 
LF_Norm_B = xlsread(filename, 'N3:N6'); %LF norm for baseline 
HF_Norm_B = xlsread(filename, 'O3:O6'); %HF norm for baseline 





LF_Norm_S1 = xlsread(filename, 'N7:N44'); %LF norm for stimuli 
LF_Norm_S2 = xlsread(filename, 'N45:N83'); 
LF_Norm_S3 = xlsread(filename, 'N84:N135'); 
  
HF_Norm_S1 = xlsread(filename, 'O7:O44'); %HF norm for stimuli 
HF_Norm_S2 = xlsread(filename, 'O45:O83');  
HF_Norm_S3 = xlsread(filename, 'O84:O135');  



















































































tonic = tonic(:)-mean(tonic(:)); 
phasic = phasic(:)-mean(phasic(:)); 
  
%pre 
tonic2 = tonic2(:)-mean(tonic2(:)); 





[C1,L1] = xcorr(LF_Norm_B/std(LF_Norm_B),tonic2/std(tonic2)); %xcorr of tonic 
and LF pre 
% plot(L1/fs,C1,'b'); 
% ylim([-65 65]); 





[C2,L2] = xcorr(LF_Norm_S1/std(LF_Norm_S1),tonic/std(tonic)); %xcorr of tonic 
and LF post 
plot(L2/fs,C2,'r',L1/fs,C1,'-.k'); 
legend('LF post 1 and Tonic', 'LF pre and Tonic'); 
ylim([-80 100]); 









[C3,L3] = xcorr(LF_Norm_S2/std(LF_Norm_S2),tonic/std(tonic)); %xcorr of tonic 
and LF post 
plot(L3/fs,C3,'r',L1/fs,C1,'-.k'); 
ylim([-80 100]); 
legend('LF post 2 and Tonic', 'LF pre and Tonic'); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 




[C4,L4] = xcorr(LF_Norm_S3/std(LF_Norm_S3),tonic/std(tonic)); %xcorr of tonic 
and LF post 
plot(L4/fs,C4, 'r',L1/fs,C1,'-.k'); 
ylim([-80 100]); 
legend('LF post 3 and Tonic', 'LF pre and Tonic'); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 
title('Subject 13: xcorr LF3 and Tonic'); 
  




[C5,L5] = xcorr(HF_Norm_B/std(HF_Norm_B),phasic2/std(phasic2));  
% plot(L5/fs,C5,'b'); 
% ylim([-80 80]); 




[C6,L6] = xcorr(HF_Norm_S1/std(HF_Norm_S1),phasic/std(phasic));  
plot(L6/fs,C6,'r', L5/fs,C5,'-.k'); 
ylim([-80 100]); 
legend('HF post 1 and Phasic', 'HF pre and Phasic'); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 




[C7,L7] = xcorr(HF_Norm_S2/std(HF_Norm_S2),phasic/std(phasic));  
plot(L7/fs,C7,'r',L5/fs,C5,'-.k'); 
ylim([-80 100]); 
legend('HF post 2 and Phasic', 'HF pre and Phasic'); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 







[C8,L8] = xcorr(HF_Norm_S3/std(HF_Norm_S3),phasic/std(phasic));  
plot(L8/fs,C8,'r',L5/fs,C5,'-.k'); 
ylim([-80 100]); 
legend('HF post 3 and Phasic', 'HF pre and Phasic'); 
title('Subject 13:  xcorr HF3 and Phasic'); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 
hold off; 
%% subject 14 
  
filename = 'C:\Users\cruzmolinag12\Documents\HRV\subject 14'; 
  
%used to plot log(LF norm) at baseline and during stimuli for subject 14 
LF_Norm_B = xlsread(filename, 'N3:N12'); %LF norm for baseline 
HF_Norm_B = xlsread(filename, 'O3:O12'); %HF norm for baseline 
Time_B = xlsread(filename, 'C3:C12'); %Time for baseline  
LF_Norm_S1 = xlsread(filename, 'N13:N45'); %LF norm for stimuli 
LF_Norm_S2 = xlsread(filename, 'N46:N127'); 
LF_Norm_S3 = xlsread(filename, 'N128:N195'); 
  
HF_Norm_S1 = xlsread(filename, 'O13:O45'); %HF norm for stimuli 
HF_Norm_S2 = xlsread(filename, 'O46:O127'); 
HF_Norm_S3 = xlsread(filename, 'O128:O195'); 





















































































tonic = tonic(:)-mean(tonic(:)); 
phasic = phasic(:)-mean(phasic(:)); 
  
%pre 
tonic2 = tonic2(:)-mean(tonic2(:)); 








[C1,L1] = xcorr(LF_Norm_B/std(LF_Norm_B),tonic2/std(tonic2)); %xcorr of tonic 
and LF pre 
% plot(L1/fs,C1,'b'); 
% ylim([-65 65]); 





[C2,L2] = xcorr(LF_Norm_S1/std(LF_Norm_S1),tonic/std(tonic)); %xcorr of tonic 
and LF post 
plot(L2/fs,C2,'r',L1/fs,C1,'-.k'); 
legend('LF post 1 and Tonic', 'LF pre and Tonic'); 
ylim([-80 100]); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 




[C3,L3] = xcorr(LF_Norm_S2/std(LF_Norm_S2),tonic/std(tonic)); %xcorr of tonic 
and LF post 
plot(L3/fs,C3,'r',L1/fs,C1,'-.k'); 
ylim([-80 100]); 
legend('LF post 2 and Tonic', 'LF pre and Tonic'); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 




[C4,L4] = xcorr(LF_Norm_S3/std(LF_Norm_S3),tonic/std(tonic)); %xcorr of tonic 
and LF post 
plot(L4/fs,C4, 'r',L1/fs,C1,'-.k'); 
ylim([-80 100]); 
legend('LF post 3 and Tonic', 'LF pre and Tonic'); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 
title('Subject 14: xcorr LF3 and Tonic'); 
  




[C5,L5] = xcorr(HF_Norm_B/std(HF_Norm_B),phasic2/std(phasic2));  
% plot(L5/fs,C5,'b'); 
% ylim([-80 80]); 










legend('HF post 1 and Phasic', 'HF pre and Phasic'); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 




[C7,L7] = xcorr(HF_Norm_S2/std(HF_Norm_S2),phasic/std(phasic));  
plot(L7/fs,C7,'r',L5/fs,C5,'-.k'); 
ylim([-80 100]); 
legend('HF post 2 and Phasic', 'HF pre and Phasic'); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 




[C8,L8] = xcorr(HF_Norm_S3/std(HF_Norm_S3),phasic/std(phasic));  
plot(L8/fs,C8,'r',L5/fs,C5,'-.k'); 
ylim([-80 100]); 
legend('HF post 3 and Phasic', 'HF pre and Phasic'); 
title('Subject 14:  xcorr HF3 and Phasic'); 




%% subject 15 
  
filename = 'C:\Users\cruzmolinag12\Documents\HRV\subject 15'; 
  
%used to plot log(LF norm) at baseline and during stimuli for subject 15 
LF_Norm_B = xlsread(filename, 'N3:N5'); %LF norm for baseline 
HF_Norm_B = xlsread(filename, 'O3:O5'); %HF norm for baseline 
Time_B = xlsread(filename, 'C3:C5'); %Time for baseline  
  
LF_Norm_S1 = xlsread(filename, 'N6:N41'); %LF norm for stimuli 
LF_Norm_S2 = xlsread(filename, 'N42:N87');  
LF_Norm_S3 = xlsread(filename, 'N88:N246');  
HF_Norm_S1 = xlsread(filename, 'O6:O41'); %HF norm for stimuli 
HF_Norm_S2 = xlsread(filename, 'O42:O87'); 
HF_Norm_S3 = xlsread(filename, 'O88:O246'); 
  























































































tonic = tonic(:)-mean(tonic(:)); 
phasic = phasic(:)-mean(phasic(:)); 
  
%pre 
tonic2 = tonic2(:)-mean(tonic2(:)); 





[C1,L1] = xcorr(LF_Norm_B/std(LF_Norm_B),tonic2/std(tonic2)); %xcorr of tonic 
and LF pre 
% plot(L1/fs,C1,'b'); 
% ylim([-65 65]); 





[C2,L2] = xcorr(LF_Norm_S1/std(LF_Norm_S1),tonic/std(tonic)); %xcorr of tonic 
and LF post 
plot(L2/fs,C2,'r',L1/fs,C1,'-.k'); 
legend('LF post 1 and Tonic', 'LF pre and Tonic'); 
ylim([-80 100]); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 




[C3,L3] = xcorr(LF_Norm_S2/std(LF_Norm_S2),tonic/std(tonic)); %xcorr of tonic 
and LF post 
plot(L3/fs,C3,'r',L1/fs,C1,'-.k'); 
ylim([-80 100]); 
legend('LF post 2 and Tonic', 'LF pre and Tonic'); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 







[C4,L4] = xcorr(LF_Norm_S3/std(LF_Norm_S3),tonic/std(tonic)); %xcorr of tonic 
and LF post 
plot(L4/fs,C4, 'r',L1/fs,C1,'-.k'); 
ylim([-80 100]); 
legend('LF post 3 and Tonic', 'LF pre and Tonic'); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 
title('Subject 15: xcorr LF3 and Tonic'); 
  




[C5,L5] = xcorr(HF_Norm_B/std(HF_Norm_B),phasic2/std(phasic2));  
% plot(L5/fs,C5,'b'); 
% ylim([-80 80]); 




[C6,L6] = xcorr(HF_Norm_S1/std(HF_Norm_S1),phasic/std(phasic));  
plot(L6/fs,C6,'r', L5/fs,C5,'-.k'); 
ylim([-80 100]); 
legend('HF post 1 and Phasic', 'HF pre and Phasic'); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 




[C7,L7] = xcorr(HF_Norm_S2/std(HF_Norm_S2),phasic/std(phasic));  
plot(L7/fs,C7,'r',L5/fs,C5,'-.k'); 
ylim([-80 100]); 
legend('HF post 2 and Phasic', 'HF pre and Phasic'); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 




[C8,L8] = xcorr(HF_Norm_S3/std(HF_Norm_S3),phasic/std(phasic));  
plot(L8/fs,C8,'r',L5/fs,C5,'-.k'); 
ylim([-80 100]); 
legend('HF post 3 and Phasic', 'HF pre and Phasic'); 
title('Subject 15:  xcorr HF3 and Phasic'); 




%% subject 16 
  
filename = 'C:\Users\cruzmolinag12\Documents\HRV\subject 16'; 
  
%used to plot log(LF norm) at baseline and during stimuli for subject 16 




HF_Norm_B = xlsread(filename, 'O3:O12'); %HF norm for baseline 
Time_B = xlsread(filename, 'C3:C12'); %Time for baseline  
  
LF_Norm_S1 = xlsread(filename, 'N13:N43'); %LF norm for stimuli 
LF_Norm_S2 = xlsread(filename, 'N44:N129'); 
LF_Norm_S3 = xlsread(filename, 'N130:N174'); 
  
HF_Norm_S1 = xlsread(filename, 'O13:O43'); %HF norm for stimuli 
HF_Norm_S2 = xlsread(filename, 'O44:O129'); 
HF_Norm_S3 = xlsread(filename, 'O130:O174'); 




















































































tonic = tonic(:)-mean(tonic(:)); 
phasic = phasic(:)-mean(phasic(:)); 
  
%pre 
tonic2 = tonic2(:)-mean(tonic2(:)); 





[C1,L1] = xcorr(LF_Norm_B/std(LF_Norm_B),tonic2/std(tonic2)); %xcorr of tonic 
and LF pre 
% plot(L1/fs,C1,'b'); 
% ylim([-65 65]); 





[C2,L2] = xcorr(LF_Norm_S1/std(LF_Norm_S1),tonic/std(tonic)); %xcorr of tonic 





legend('LF post 1 and Tonic', 'LF pre and Tonic'); 
ylim([-80 100]); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 




[C3,L3] = xcorr(LF_Norm_S2/std(LF_Norm_S2),tonic/std(tonic)); %xcorr of tonic 
and LF post 
plot(L3/fs,C3,'r',L1/fs,C1,'-.k'); 
ylim([-80 100]); 
legend('LF post 2 and Tonic', 'LF pre and Tonic'); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 




[C4,L4] = xcorr(LF_Norm_S3/std(LF_Norm_S3),tonic/std(tonic)); %xcorr of tonic 
and LF post 
plot(L4/fs,C4, 'r',L1/fs,C1,'-.k'); 
ylim([-80 100]); 
legend('LF post 3 and Tonic', 'LF pre and Tonic'); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 
title('Subject 16: xcorr LF3 and Tonic'); 
  




[C5,L5] = xcorr(HF_Norm_B/std(HF_Norm_B),phasic2/std(phasic2));  
% plot(L5/fs,C5,'b'); 
% ylim([-80 80]); 




[C6,L6] = xcorr(HF_Norm_S1/std(HF_Norm_S1),phasic/std(phasic));  
plot(L6/fs,C6,'r', L5/fs,C5,'-.k'); 
ylim([-80 100]); 
legend('HF post 1 and Phasic', 'HF pre and Phasic'); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 




[C7,L7] = xcorr(HF_Norm_S2/std(HF_Norm_S2),phasic/std(phasic));  
plot(L7/fs,C7,'r',L5/fs,C5,'-.k'); 
ylim([-80 100]); 
legend('HF post 2 and Phasic', 'HF pre and Phasic'); 









[C8,L8] = xcorr(HF_Norm_S3/std(HF_Norm_S3),phasic/std(phasic));  
plot(L8/fs,C8,'r',L5/fs,C5,'-.k'); 
ylim([-80 100]); 
legend('HF post 3 and Phasic', 'HF pre and Phasic'); 
title('Subject 16:  xcorr HF3 and Phasic'); 




%% subject 17 
  
filename = 'C:\Users\cruzmolinag12\Documents\HRV\subject 17'; 
  
%used to plot log(LF norm) at baseline and during stimuli for subject 17 
LF_Norm_B = xlsread(filename, 'N3:N57'); %LF norm for baseline 
HF_Norm_B = xlsread(filename, 'O3:O57'); %HF norm for baseline 
Time_B = xlsread(filename, 'C3:C57'); %Time for baseline  
LF_Norm_S1 = xlsread(filename, 'N58:N102'); %LF norm for stimuli 
LF_Norm_S2 = xlsread(filename, 'N103:N158');  
LF_Norm_S3 = xlsread(filename, 'N159:N233');  
  
HF_Norm_S1 = xlsread(filename, 'O58:O102'); %HF norm for stimuli 
HF_Norm_S2 = xlsread(filename, 'O103:O158');  
HF_Norm_S3 = xlsread(filename, 'O159:O233');  
  
























































































phasic = phasic(:)-mean(phasic(:)); 
  
%pre 
tonic2 = tonic2(:)-mean(tonic2(:)); 





[C1,L1] = xcorr(LF_Norm_B/std(LF_Norm_B),tonic2/std(tonic2)); %xcorr of tonic 
and LF pre 
% plot(L1/fs,C1,'b'); 
% ylim([-65 65]); 





[C2,L2] = xcorr(LF_Norm_S1/std(LF_Norm_S1),tonic/std(tonic)); %xcorr of tonic 
and LF post 
plot(L2/fs,C2,'r',L1/fs,C1,'-.k'); 
legend('LF post 1 and Tonic', 'LF pre and Tonic'); 
ylim([-80 100]); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 




[C3,L3] = xcorr(LF_Norm_S2/std(LF_Norm_S2),tonic/std(tonic)); %xcorr of tonic 
and LF post 
plot(L3/fs,C3,'r',L1/fs,C1,'-.k'); 
ylim([-80 100]); 
legend('LF post 2 and Tonic', 'LF pre and Tonic'); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 




[C4,L4] = xcorr(LF_Norm_S3/std(LF_Norm_S3),tonic/std(tonic)); %xcorr of tonic 
and LF post 
plot(L4/fs,C4, 'r',L1/fs,C1,'-.k'); 
ylim([-80 100]); 
legend('LF post 3 and Tonic', 'LF pre and Tonic'); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 
title('Subject 17: xcorr LF3 and Tonic'); 
  




[C5,L5] = xcorr(HF_Norm_B/std(HF_Norm_B),phasic2/std(phasic2));  
% plot(L5/fs,C5,'b'); 








[C6,L6] = xcorr(HF_Norm_S1/std(HF_Norm_S1),phasic/std(phasic));  
plot(L6/fs,C6,'r', L5/fs,C5,'-.k'); 
ylim([-80 100]); 
legend('HF post 1 and Phasic', 'HF pre and Phasic'); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 




[C7,L7] = xcorr(HF_Norm_S2/std(HF_Norm_S2),phasic/std(phasic));  
plot(L7/fs,C7,'r',L5/fs,C5,'-.k'); 
ylim([-80 100]); 
legend('HF post 2 and Phasic', 'HF pre and Phasic'); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 




[C8,L8] = xcorr(HF_Norm_S3/std(HF_Norm_S3),phasic/std(phasic));  
plot(L8/fs,C8,'r',L5/fs,C5,'-.k'); 
ylim([-80 100]); 
legend('HF post 3 and Phasic', 'HF pre and Phasic'); 
title('Subject 17:  xcorr HF3 and Phasic'); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 
hold off; 
%% subject 18 
  
filename = 'C:\Users\cruzmolinag12\Documents\HRV\subject 18'; 
  
%used to plot log(LF norm) at baseline and during stimuli for subject 18 
LF_Norm_B = xlsread(filename, 'N3:N13'); %LF norm for baseline 
HF_Norm_B = xlsread(filename, 'O3:O13'); %HF norm for baseline 
Time_B = xlsread(filename, 'C3:C13'); %Time for baseline  
LF_Norm_S1 = xlsread(filename, 'N14:N93'); %LF norm for stimuli 
LF_Norm_S2 = xlsread(filename, 'N94:N147'); 
LF_Norm_S3 = xlsread(filename, 'N148:N254'); 
  
HF_Norm_S1 = xlsread(filename, 'O14:O93'); %HF norm for stimuli 
HF_Norm_S2 = xlsread(filename, 'O94:O147'); 
HF_Norm_S3 = xlsread(filename, 'O148:O254'); 
  



























































































tonic = tonic(:)-mean(tonic(:)); 
phasic = phasic(:)-mean(phasic(:)); 
  
%pre 
tonic2 = tonic2(:)-mean(tonic2(:)); 





[C1,L1] = xcorr(LF_Norm_B/std(LF_Norm_B),tonic2/std(tonic2)); %xcorr of tonic 
and LF pre 
% plot(L1/fs,C1,'b'); 
% ylim([-65 65]); 





[C2,L2] = xcorr(LF_Norm_S1/std(LF_Norm_S1),tonic/std(tonic)); %xcorr of tonic 
and LF post 
plot(L2/fs,C2,'r',L1/fs,C1,'-.k'); 
legend('LF post 1 and Tonic', 'LF pre and Tonic'); 
ylim([-80 100]); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 




[C3,L3] = xcorr(LF_Norm_S2/std(LF_Norm_S2),tonic/std(tonic)); %xcorr of tonic 






legend('LF post 2 and Tonic', 'LF pre and Tonic'); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 




[C4,L4] = xcorr(LF_Norm_S3/std(LF_Norm_S3),tonic/std(tonic)); %xcorr of tonic 
and LF post 
plot(L4/fs,C4, 'r',L1/fs,C1,'-.k'); 
ylim([-80 100]); 
legend('LF post 3 and Tonic', 'LF pre and Tonic'); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 
title('Subject 18: xcorr LF3 and Tonic'); 
  




[C5,L5] = xcorr(HF_Norm_B/std(HF_Norm_B),phasic2/std(phasic2));  
% plot(L5/fs,C5,'b'); 
% ylim([-80 80]); 




[C6,L6] = xcorr(HF_Norm_S1/std(HF_Norm_S1),phasic/std(phasic));  
plot(L6/fs,C6,'r', L5/fs,C5,'-.k'); 
ylim([-80 100]); 
legend('HF post 1 and Phasic', 'HF pre and Phasic'); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 




[C7,L7] = xcorr(HF_Norm_S2/std(HF_Norm_S2),phasic/std(phasic));  
plot(L7/fs,C7,'r',L5/fs,C5,'-.k'); 
ylim([-80 100]); 
legend('HF post 2 and Phasic', 'HF pre and Phasic'); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 




[C8,L8] = xcorr(HF_Norm_S3/std(HF_Norm_S3),phasic/std(phasic));  
plot(L8/fs,C8,'r',L5/fs,C5,'-.k'); 
ylim([-80 100]); 
legend('HF post 3 and Phasic', 'HF pre and Phasic'); 
title('Subject 18:  xcorr HF3 and Phasic'); 







%% subject 19 
  
filename = 'C:\Users\cruzmolinag12\Documents\HRV\subject 19'; 
  
%used to plot log(LF norm) at baseline and during stimuli for subject 19 
LF_Norm_B = xlsread(filename, 'N3:N4'); %LF norm for baseline 
HF_Norm_B = xlsread(filename, 'O3:O4'); %HF norm for baseline 
Time_B = xlsread(filename, 'C3:C4'); %Time for baseline  
LF_Norm_S1 = xlsread(filename, 'N5:N30'); %LF norm for stimuli 
LF_Norm_S2 = xlsread(filename, 'N31:N66'); 
LF_Norm_S3 = xlsread(filename, 'N67:N125'); 
  
HF_Norm_S1 = xlsread(filename, 'O5:O30'); %HF norm for stimuli 
HF_Norm_S2 = xlsread(filename, 'O31:O66'); 
HF_Norm_S3 = xlsread(filename, 'O67:O125'); 






































































tonic = tonic(:)-mean(tonic(:)); 
phasic = phasic(:)-mean(phasic(:)); 
  
%pre 
tonic2 = tonic2(:)-mean(tonic2(:)); 





[C1,L1] = xcorr(LF_Norm_B/std(LF_Norm_B),tonic2/std(tonic2)); %xcorr of tonic 
and LF pre 
% plot(L1/fs,C1,'b'); 
% ylim([-65 65]); 





[C2,L2] = xcorr(LF_Norm_S1/std(LF_Norm_S1),tonic/std(tonic)); %xcorr of tonic 
and LF post 
plot(L2/fs,C2,'r',L1/fs,C1,'-.k'); 
legend('LF post 1 and Tonic', 'LF pre and Tonic'); 
ylim([-80 100]); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 







[C3,L3] = xcorr(LF_Norm_S2/std(LF_Norm_S2),tonic/std(tonic)); %xcorr of tonic 
and LF post 
plot(L3/fs,C3,'r',L1/fs,C1,'-.k'); 
ylim([-80 100]); 
legend('LF post 2 and Tonic', 'LF pre and Tonic'); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 




[C4,L4] = xcorr(LF_Norm_S3/std(LF_Norm_S3),tonic/std(tonic)); %xcorr of tonic 
and LF post 
plot(L4/fs,C4, 'r',L1/fs,C1,'-.k'); 
ylim([-80 100]); 
legend('LF post 3 and Tonic', 'LF pre and Tonic'); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 
title('Subject 19: xcorr LF3 and Tonic'); 
  




[C5,L5] = xcorr(HF_Norm_B/std(HF_Norm_B),phasic2/std(phasic2));  
% plot(L5/fs,C5,'b'); 
% ylim([-80 80]); 




[C6,L6] = xcorr(HF_Norm_S1/std(HF_Norm_S1),phasic/std(phasic));  
plot(L6/fs,C6,'r', L5/fs,C5,'-.k'); 
ylim([-80 100]); 
legend('HF post 1 and Phasic', 'HF pre and Phasic'); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 




[C7,L7] = xcorr(HF_Norm_S2/std(HF_Norm_S2),phasic/std(phasic));  
plot(L7/fs,C7,'r',L5/fs,C5,'-.k'); 
ylim([-80 100]); 
legend('HF post 2 and Phasic', 'HF pre and Phasic'); 
xlabel('Time delay (s)'); 
ylabel('Correlation'); 




[C8,L8] = xcorr(HF_Norm_S3/std(HF_Norm_S3),phasic/std(phasic));  
plot(L8/fs,C8,'r',L5/fs,C5,'-.k'); 
ylim([-80 100]); 




title('Subject 19:  xcorr HF3 and Phasic'); 
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